DENND5A-related developmental and epileptic encephalopathy (DEE49) is an autosomal recessive disorder caused by biallelic loss-of-function variants in DENND5A, a DENN-domain protein that is both a candidate Rab guanine nucleotide exchange factor and a binding partner of the Crumbs apical polarity proteins MUPP1 and PALS1. The mechanism is developmental rather than primarily electrical: without DENND5A, apical neural progenitors misorient their mitotic spindles away from the ventricular surface, divide asymmetrically instead of symmetrically, and prematurely exit the cell cycle to differentiate into neurons. The progenitor pool is depleted before neurogenesis is complete, producing primary microcephaly, ventriculomegaly, cortical malformation and corpus callosum dysgenesis; the mispositioned, prematurely born neurons form aberrant connections and seizures follow. Cerebral calcifications and coarse facial features were part of the original clinical description.
Ask a research question about DENND5A-Related Developmental and Epileptic Encephalopathy. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
Conditions with similar clinical presentations that must be differentiated from DENND5A-Related Developmental and Epileptic Encephalopathy:
name: DENND5A-Related Developmental and Epileptic Encephalopathy
creation_date: "2026-08-20T09:30:00Z"
category: Mendelian
synonyms:
- Developmental and epileptic encephalopathy 49
- DEE49
- EIEE49
- Epileptic encephalopathy, early infantile, 49
- DENND5A deficiency
description: >-
DENND5A-related developmental and epileptic encephalopathy (DEE49) is an autosomal
recessive disorder caused by biallelic loss-of-function variants in DENND5A, a
DENN-domain protein that is both a candidate Rab guanine nucleotide exchange factor and
a binding partner of the Crumbs apical polarity proteins MUPP1 and PALS1. The mechanism
is developmental rather than primarily electrical: without DENND5A, apical neural
progenitors misorient their mitotic spindles away from the ventricular surface, divide
asymmetrically instead of symmetrically, and prematurely exit the cell cycle to
differentiate into neurons. The progenitor pool is depleted before neurogenesis is
complete, producing primary microcephaly, ventriculomegaly, cortical malformation and
corpus callosum dysgenesis; the mispositioned, prematurely born neurons form aberrant
connections and seizures follow. Cerebral calcifications and coarse facial features
were part of the original clinical description.
disease_term:
preferred_term: developmental and epileptic encephalopathy, 49
term:
id: MONDO:0015002
label: developmental and epileptic encephalopathy, 49
parents:
- Epilepsy
- Neurological Disease
inheritance:
- name: Autosomal recessive
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
description: >-
Biallelic - homozygous in consanguineous families or compound heterozygous. In the
24-person cohort, 14 individuals were homozygous and 10 compound heterozygous. No
point mutation was found homozygous in gnomAD, which is the population-genetic
argument that two damaged alleles are not tolerated.
evidence:
- reference: PMID:27866705
reference_title: "Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "we have identified an epileptic encephalopathy additionally featuring
cerebral calcifications and coarse facial features caused by recessive
loss-of-function mutations in DENND5A"
explanation: >-
The founding gene-disease report, establishing recessive loss of function.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "None of the DENND5A point mutations in the cohort were found in the
homozygous state among 140,000 individuals on gnomAD, a database that removes
individuals affected by severe pediatric disease, indicating that biallelic
pathogenic variants are likely incompatible with normal development"
explanation: >-
Population-genetic support for the recessive model and for the severity of the
biallelic state.
pathophysiology:
- name: Biallelic DENND5A Loss-of-Function Variants
biological_scale: MOLECULAR
description: >-
The initiating lesion. Thirty unique variants have been reported across 22 families,
spread over the whole protein rather than clustering in one domain: nine in the DENN
domain, two in RUN1, six in PLAT, four in RUN2 and four in the linkers, plus copy
number and splice-site variants. That distribution is itself mechanistically
informative - it is what a loss-of-function disorder looks like, as opposed to the
domain-restricted clustering seen in gain-of-function DEEs.
genes:
- preferred_term: DENND5A
term:
id: hgnc:19344
label: DENND5A
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Thirty unique DENND5A variants were identified across the 14 homozygous and
10 compound heterozygous individuals"
explanation: >-
Establishes the size and allelic architecture of the reported variant spectrum.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The coding variants span the length of the protein including nine in the
DENN domain, two in the RUN1 domain, six in the PLAT domain, four in the RUN2
domain, and four in predicted linker regions between the folded modules"
explanation: >-
Documents that variants are distributed across the protein rather than clustered,
consistent with loss of function.
downstream:
- target: Reduced DENND5A Protein
causal_link_type: DIRECT
description: >-
Every patient-derived cell line examined shows less DENND5A protein, whatever the
variant class.
- name: Reduced DENND5A Protein
biological_scale: MOLECULAR
description: >-
The convergent proximal consequence. Cells from five cohort members - three
iPSC-derived neural progenitor lines and two immortalized lymphoblast lines, spanning
frameshift, nonsense and missense variants - all show reduced DENND5A protein. The
reduction is post-transcriptional: patient mRNA levels do not differ significantly
from controls, so the protein is lost after it is made rather than because the
transcript is absent. This node is curated separately from the variants above because
the protein and transcript measurements come apart, and it is the protein measurement
that carries the loss-of-function claim.
cell_types:
- preferred_term: neural progenitor cell
term:
id: CL:0011020
label: neural progenitor cell
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "All patient-derived cells exhibit a reduction in DENND5A protein
(Supplementary Fig. 2a, b), supporting that disease phenotypes are a result of
protein loss of function"
explanation: >-
The direct measurement establishing protein loss of function across variant classes.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "A rather poor correlation between DENND5A mRNA and protein levels was
observed as DENND5A mRNA expression from patient-derived cells did not differ
significantly from controls"
explanation: >-
Locates the defect after transcription, which is why the protein and transcript
claims are curated as separate measurements.
downstream:
- target: Loss of DENND5A-MUPP1/PALS1 Association at the Apical Membrane
causal_link_type: DIRECT
description: >-
Less protein means less of the polarity-complex interaction that follows.
- target: Impaired Rab-Directed Membrane Trafficking
causal_link_type: DIRECT
description: >-
The second, parallel arm - the DENN domain's own predicted enzymatic function.
- name: Loss of DENND5A-MUPP1/PALS1 Association at the Apical Membrane
biological_scale: MOLECULAR
description: >-
DENND5A binds MUPP1 and PALS1, two components of the Crumbs apical polarity complex
that is required for symmetric division of neural progenitors. The interaction is
conformation-dependent: full-length DENND5A binds these partners only weakly, because
the binding region makes intramolecular contacts with the DENN domain, and a
conformational change is needed to expose it. Losing DENND5A therefore removes a
conformationally gated link into the apical polarity machinery, which is the point at
which this trafficking protein becomes a developmental one.
protein_complexes:
- preferred_term: Crumbs apical polarity complex (MUPP1-PALS1)
biological_processes:
- preferred_term: establishment or maintenance of cell polarity
term:
id: GO:0007163
label: establishment or maintenance of cell polarity
modifier: DECREASED
cellular_components:
- preferred_term: apical plasma membrane
term:
id: GO:0016324
label: apical plasma membrane
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Mass spectrometry of purified proteins revealed members of the Crb polarity
complex, MUPP1, and PALS1, as major DENND5A binding partners"
explanation: >-
Identifies the polarity-complex partners by unbiased proteomics.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "This suggests a conformational change in DENND5A is necessary to expose the
binding site for MUPP1/PALS1. In fact, full-length DENND5A has limited interaction
with these proteins"
explanation: >-
Establishes that the interaction is gated by DENND5A's conformation, which is what
the R710H variant later exploits.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "We demonstrate that DENND5A interacts with Pals1/MUPP1, components of the
Crumbs apical polarity complex required for symmetrical division of neural
progenitor cells"
explanation: >-
Links the interaction to the specific cellular process the disorder disrupts.
downstream:
- target: Mitotic Spindle Misorientation in Apical Neural Progenitors
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >-
How the polarity-complex interaction is transduced to the spindle is not
established. DENND5A is not required to deliver MUPP1/PALS1 to the apical membrane -
those proteins still localize apically in knockout rosettes - so the route from
interaction to spindle angle runs through some other, unidentified step.
- name: Impaired Rab-Directed Membrane Trafficking
biological_scale: MOLECULAR
description: >-
The second, older mechanistic thread, and the one the gene is named for. DENND5A
carries a DENN domain, the module that confers guanine nucleotide exchange factor
activity toward Rab GTPases, and two RUN domains through which it binds active Rab6
and sorting nexin 1. Structural modeling qualifies this: the predicted Rab enzymatic
site may be occluded by the DENN-RUN1/PLAT interaction in the closed conformation,
while Rab6 binding to RUN1 needs no conformational change - so the two functions are
predicted to require different conformations of the same protein. This node is kept
separate from the polarity arm rather than merged into it, because no source available
to this entry shows that trafficking loss is what causes the spindle defect.
molecular_functions:
- preferred_term: guanyl-nucleotide exchange factor activity
term:
id: GO:0005085
label: guanyl-nucleotide exchange factor activity
modifier: DECREASED
biological_processes:
- preferred_term: vesicle-mediated transport
term:
id: GO:0016192
label: vesicle-mediated transport
modifier: DECREASED
- preferred_term: retrograde transport, endosome to Golgi
term:
id: GO:0042147
label: retrograde transport, endosome to Golgi
evidence:
- reference: PMID:27866705
reference_title: "Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "DENND5A contains a DENN domain, an evolutionarily ancient enzymatic module
conferring guanine nucleotide exchange factor (GEF) activity to multiple proteins
serving as GEFs for Rabs, which are key regulators of membrane trafficking"
explanation: >-
Establishes the DENN domain's expected enzymatic role in membrane trafficking.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: COMPUTATIONAL
snippet: "we aligned the co-crystal structure of DENND1B and Rab35 with the predicted
DENND5A structure and found that the predicted Rab enzymatic site in DENND5A may be
occluded by interactions between the DENN and RUN1 (RPIP8, UNC-14 and NESCA)/PLAT
(Polycystin-1, Lipoxygenase, Alpha-Toxin) domains"
explanation: >-
Curated PARTIAL: a structural prediction that qualifies the GEF assignment rather
than a measurement of exchange activity. No source available to this entry reports
DENND5A GEF activity assayed directly against a Rab substrate.
downstream:
- target: Neurotrophin Receptor Upregulation and Enhanced Downstream Signaling
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >-
Knockdown raises neurotrophin receptor levels, but by what trafficking step is not
identified.
- name: Neurotrophin Receptor Upregulation and Enhanced Downstream Signaling
biological_scale: CELLULAR
description: >-
In the founding study, knocking DENND5A down altered neuronal development, and the
change appeared to be mediated by an increase in neurotrophin receptors and hence in
downstream signaling. This is a knockdown-derived account from 2016 and has not been
reproduced in the patient-derived systems used in the 2024 cohort study, so it is
curated as a parallel arm reaching the same developmental endpoint rather than as a
step in the spindle chain.
biological_processes:
- preferred_term: neurotrophin TRK receptor signaling pathway
term:
id: GO:0048011
label: neurotrophin TRK receptor signaling pathway
modifier: INCREASED
evidence:
- reference: PMID:27866705
reference_title: "Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Knockdown of DENND5A leads to striking alterations in neuronal development.
Mechanistically, these changes appear to result from upregulation of neurotrophin
receptors, leading to enhanced downstream signaling"
explanation: >-
The knockdown result and the receptor-upregulation account offered for it. The
source's own hedge - "appear to result from" - is preserved in the description.
downstream:
- target: Premature Neuronal Differentiation and Cell Cycle Exit
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >-
Both arms converge on altered neuronal development; the intermediates on this one
are not identified.
- name: Mitotic Spindle Misorientation in Apical Neural Progenitors
biological_scale: CELLULAR
description: >-
The rate-limiting cellular defect. In human iPSC-derived neural rosettes - a polarized
in vitro model of early neural development - the angle between the cleavage plane and
the apical surface collapses when DENND5A is absent. Wild-type progenitors divide with
a mean spindle angle of 57.1 degrees, close to the plane that gives both daughters
equal access to the apical surface; knockout progenitors divide at 26.0 degrees, and
an overwhelming majority fall below 45 degrees.
cell_types:
- preferred_term: apical radial glial cell
term:
id: CL:0000681
label: radial glial cell
biological_processes:
- preferred_term: establishment of mitotic spindle orientation
term:
id: GO:0000132
label: establishment of mitotic spindle orientation
modifier: DECREASED
cellular_components:
- preferred_term: mitotic spindle
term:
id: GO:0072686
label: mitotic spindle
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "the spindle angle among cells dividing within WT (M = 57.1°, Mdn = 65.4°, SD
= 25.9) and KO (M = 26.0°, Mdn = 20.1°, SD = 19.0) rosettes differed significantly"
explanation: >-
The quantitative spindle-angle measurement in human iPSC-derived neural rosettes.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "These phenotypes result from misalignment of the mitotic spindle in apical
neural progenitors"
explanation: >-
The authors' own placement of spindle misalignment as the causal step.
downstream:
- target: Loss of Symmetric Proliferative Division
causal_link_type: DIRECT
description: >-
Spindle angle sets the division plane, and hence whether both daughters retain apical
contact.
- name: Loss of Symmetric Proliferative Division
biological_scale: CELLULAR
description: >-
An oblique cleavage plane means only one daughter keeps contact with the apical
ventricular surface and inherits the apical determinants MUPP1 and PALS1. The other is
displaced basally and receives less of the stem-cell-niche signal, so it is biased
toward commitment. The division that should have produced two progenitors produces one
progenitor and one committed cell.
cell_types:
- preferred_term: apical radial glial cell
term:
id: CL:0000681
label: radial glial cell
biological_processes:
- preferred_term: symmetric cell division
term:
id: GO:0098725
label: symmetric cell division
modifier: DECREASED
- preferred_term: asymmetric cell division
term:
id: GO:0008356
label: asymmetric cell division
modifier: INCREASED
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "indicating that DENND5A KO results in increased levels of oblique asymmetric
cell divisions and the ability for apical progenitors to self-renew is severely
compromised"
explanation: >-
States the division-mode shift and its consequence for self-renewal.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Cells lacking DENND5A orient away from the proliferative apical domain
surrounding the ventricles, biasing daughter cells towards a more fate-committed
state"
explanation: >-
Connects loss of apical contact to the fate bias in the daughter cells.
downstream:
- target: Premature Neuronal Differentiation and Cell Cycle Exit
causal_link_type: DIRECT
description: >-
The committed daughter differentiates instead of dividing again.
- target: Neural Progenitor Pool Depletion
causal_link_type: DIRECT
description: >-
Each non-self-renewing division removes a progenitor from the pool.
- name: Premature Neuronal Differentiation and Cell Cycle Exit
biological_scale: CELLULAR
description: >-
Knockout progenitors do not merely divide differently, they are inherently more likely
to leave the cycle. One day after passaging into progenitor maintenance medium -
conditions meant to keep them undifferentiated - 47.29 percent of knockout cells had
developed neuronal processes against 10.67 percent of wild-type. The same shift is
present in the adult mouse: knock-in animals have a higher proportion of NeuN-positive
post-mitotic neurons in the subventricular zone. This is a propensity of the cells
themselves, which is why it is curated as its own node with an input from the division
defect rather than only as its consequence.
cell_types:
- preferred_term: neural progenitor cell
term:
id: CL:0011020
label: neural progenitor cell
biological_processes:
- preferred_term: neuron differentiation
term:
id: GO:0030182
label: neuron differentiation
modifier: INCREASED
- preferred_term: cell fate commitment
term:
id: GO:0045165
label: cell fate commitment
modifier: INCREASED
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Our results suggest that DENND5A expression promotes stemness and its loss
drives cell cycle exit and premature differentiation into neuronal phenotypes"
explanation: >-
The authors' summary of the differentiation phenotype across their in vitro and in
vivo measurements.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Human induced pluripotent stem cells lacking DENND5A fail to undergo
symmetric cell division with an inherent propensity to differentiate into neurons"
explanation: >-
States the propensity as inherent to the cells, not only a consequence of the
division geometry.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "KI mice have a significantly higher percentage of post-mitotic neurons
expressing NeuN compared to WT mice"
explanation: >-
In vivo corroboration in the knock-in mouse subventricular zone.
downstream:
- target: Neural Progenitor Pool Depletion
causal_link_type: DIRECT
description: >-
Cells that differentiate are no longer available to divide.
- target: Aberrant Positioning and Connectivity of Prematurely Born Neurons
causal_link_type: DIRECT
description: >-
Neurons born early and in the wrong place make the wrong contacts.
- name: Neural Progenitor Pool Depletion
biological_scale: CELLULAR
description: >-
The two upstream defects - fewer self-renewing divisions and more cells leaving the
cycle - both subtract from the same pool, and the pool is measurably smaller. Equal
numbers of wild-type and knockout progenitors plated together diverge within two days:
1008 wild-type cells per well against 614 knockout, and by 72 hours 1685 against 683.
Wild-type numbers climb while knockout numbers stay nearly flat.
cell_types:
- preferred_term: neural progenitor cell
term:
id: CL:0011020
label: neural progenitor cell
biological_processes:
- preferred_term: neural precursor cell proliferation
term:
id: GO:0061351
label: neural precursor cell proliferation
modifier: DECREASED
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "WT NPCs then rapidly increased in number whereas the number of KO NPCs
remained relatively stable"
explanation: >-
The proliferation divergence between wild-type and knockout progenitors.
downstream:
- target: Shortened Period of Neurogenesis
causal_link_type: DIRECT
description: >-
Fewer progenitors, entering the pool later and leaving it earlier, means neurogenesis
runs out sooner.
- name: Shortened Period of Neurogenesis
biological_scale: TISSUE
description: >-
The developmental endpoint of the progenitor arithmetic. Neurogenesis in the developing
cortex is bounded by how long a progenitor pool of sufficient size persists; when the
pool is depleted early, the window closes early and fewer neurons, of fewer lineages,
are produced.
biological_processes:
- preferred_term: neurogenesis
term:
id: GO:0022008
label: neurogenesis
modifier: DECREASED
- preferred_term: cerebral cortex development
term:
id: GO:0021987
label: cerebral cortex development
modifier: DECREASED
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "biasing daughter cells towards a more fate-committed state, ultimately
shortening the period of neurogenesis"
explanation: >-
Names the shortened neurogenic period as the outcome of the fate bias.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Ultimately, this results in a shortened period of neurogenesis which leads to
microcephaly and/or observable abnormalities in gray and white matter structures"
explanation: >-
The authors' own statement of the link from shortened neurogenesis to the structural
brain phenotype.
downstream:
- target: Reduced Brain Volume and Cortical Malformation
causal_link_type: DIRECT
description: >-
Too few neurons, produced over too short a window.
- name: Reduced Brain Volume and Cortical Malformation
biological_scale: TISSUE
description: >-
The structural phenotype: microcephaly, reduced white matter volume, pachygyria with
an occipital predominance, basal ganglia and diencephalic-mesencephalic junction dysplasia,
corpus callosum agenesis or hypoplasia, and striatal and periventricular calcifications.
Corpus callosum volume in the cohort was normal, thin or absent, never increased - a
detail that distinguishes this from the LIS1 tubulinopathy differential.
locations:
- preferred_term: cerebral cortex
term:
id: UBERON:0000956
label: cerebral cortex
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "cortical malformations, particularly with pachygyria involving the occipital
lobes, a reduced volume of the white matter with associated striatal and
periventricular calcifications and ventriculomegaly, agenesis or severe
dysplasia/hypoplasia of the corpus callosum"
explanation: >-
The structural MRI phenotype as reported in the cohort.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "These imaging studies highlight the heterogenous neuroanatomical
manifestations of biallelic DENND5A variants, but certain features including volume
loss, ventriculomegaly, and hypoplasia of the corpus callosum appear more frequently"
explanation: >-
Records both the heterogeneity and the recurrent features.
downstream:
- target: Compensatory Ventriculomegaly
causal_link_type: DIRECT
description: >-
The authors read the ventricular enlargement as filling volume the missing neurons
would have occupied.
- name: Compensatory Ventriculomegaly
biological_scale: TISSUE
description: >-
Ventricular enlargement is present in 15 of 24 individuals and is reproduced in the
knock-in mouse by 7T MRI. The 2024 study reads it as compensatory - space vacated by
the reduced neuronal volume - rather than as an independent obstructive or resorptive
process. That reading is an interpretation offered by the source, not a measurement,
and is recorded as such.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The reduced volume of neurons likely leads to compensatory ventriculomegaly"
explanation: >-
The compensatory interpretation, hedged by the source with "likely" and preserved
here as such.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "In vivo 7T MRI scans revealed that DENND5A KI mice have significantly
enlarged lateral ventricles (MWT = 4.8 mm3, MKI = 6.6 mm3, SDWT = 1.3, SDKI = 2.4,
two-tailed Mann-Whitney U, Z = −2.117, p = 0.034), consistent with ventriculomegaly"
explanation: >-
Quantitative in vivo reproduction of the ventriculomegaly in the mouse model.
- name: Aberrant Positioning and Connectivity of Prematurely Born Neurons
biological_scale: TISSUE
description: >-
Neurons born too early and displaced from the ventricular surface end up in the wrong
laminar position and, where they escape apoptosis, form synaptic contacts they should
not have. This is the proposed bridge from the developmental defect to the epilepsy,
and it is the least directly evidenced step in the chain: it is asserted in the
authors' disease model, not measured. The edge into seizure generation is marked
accordingly.
cell_types:
- preferred_term: neuron
term:
id: CL:0000540
label: neuron
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "improperly positioned prematurely-born neurons that do not undergo apoptosis
and form aberrant synaptic contacts results in seizures that can further adversely
affect development"
explanation: >-
Curated PARTIAL: this is the proposed disease model, stated in the discussion, not a
measurement of synaptic connectivity in patient or model tissue.
downstream:
- target: Seizure Generation and Developmental and Epileptic Encephalopathy
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
description: >-
No source available to this entry measures excitation-inhibition balance, network
synchrony or intrinsic excitability in DENND5A-deficient neurons. The step from
aberrant connectivity to seizures is therefore inferential.
- name: Seizure Generation and Developmental and Epileptic Encephalopathy
biological_scale: ORGANISM
conforms_to: "epilepsy_excitation_inhibition_imbalance#Recurrent Unprovoked Seizures"
description: >-
Recurrent, usually drug-resistant seizures in 21 of 24 individuals, with focal to
bilateral tonic-clonic the most common type. Seizures then act back on development, the
defining feature of a developmental and epileptic encephalopathy. Conformance attaches
at the module's Recurrent Unprovoked Seizures node - the clinical endpoint - and not at
the upstream excitation-inhibition or hyperexcitability nodes, because no ion-channel or
synaptic measurement exists for this disorder to support those. The developmental
encephalopathy here has an independent origin in the neurogenesis defect and is not
solely seizure-driven.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The phenotypes observed in more than 50% of individuals with biallelic
DENND5A variants were seizures (21/24), microcephaly (16/24), ventriculomegaly
(15/24), hypertonia (14/24), cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
explanation: >-
Quantifies seizures as the most frequent feature of the cohort.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Developmental and epileptic encephalopathies (DEEs) feature altered brain
development, developmental delay and seizures, with seizures exacerbating
developmental delay"
explanation: >-
States the DEE construct - seizures acting back on development - that this endpoint
instantiates.
notes: >-
Three of the 24 individuals had no seizures at all, so the seizure phenotype is not
obligate even though the disorder is classified as a DEE. Those individuals also had
milder neurological findings, which is consistent with the variant-class severity
gradient recorded in the genetic section.
mechanistic_hypotheses:
- hypothesis_group_id: apical_polarity_spindle_orientation_model
status: CANONICAL
description: >-
Loss of DENND5A removes a conformationally gated link to the MUPP1/PALS1 apical
polarity complex, apical progenitors misorient their mitotic spindles, symmetric
proliferative division is lost, the progenitor pool is depleted early, and neurogenesis
is cut short - producing microcephaly and cortical malformation, with seizures arising
from the mispositioned neurons. This is the account with quantitative support in human
iPSC-derived cells and corroboration in mouse and zebrafish.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "This study provides a mechanism for DENND5A-related DEE that may be
generalizable to other developmental conditions and provides variant-specific
clinical information for physicians and families"
explanation: >-
The authors' framing of this as the mechanism for the disorder.
- hypothesis_group_id: rab_trafficking_neurotrophin_model
status: ALTERNATIVE
description: >-
Loss of DENND5A's Rab-directed trafficking function raises neurotrophin receptor
abundance and hence downstream signaling, and it is that signaling change that alters
neuronal development. This was the founding account and it remains the one predicted by
the protein's domain architecture, but it rests on knockdown experiments and has not
been re-examined in the patient-derived neural progenitor and rosette systems that
established the polarity mechanism. The two accounts are not mutually exclusive - a
single protein with two conformations may serve both - and the trafficking arm is
retained here rather than retired.
evidence:
- reference: PMID:27866705
reference_title: "Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Mechanistically, these changes appear to result from upregulation of
neurotrophin receptors, leading to enhanced downstream signaling"
explanation: >-
The founding mechanistic proposal, in the source's own hedged wording.
phenotypes:
- category: Neurological
name: Global Developmental Delay
description: >-
The "D" in this developmental and epileptic encephalopathy, and the single most frequent
feature of the disorder - more frequent than the seizures. Twenty-three of the 24
reported individuals presented with or had a history of global developmental delay; the
one exception, participant 8, carries biallelic missense variants and is also the only
cohort member with no intellectual disability. That single exception is what keeps this
VERY_FREQUENT rather than OBLIGATE.
frequency: VERY_FREQUENT
phenotype_term:
preferred_term: Global developmental delay
term:
id: HP:0001263
label: Global developmental delay
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Failure to meet key developmental milestones was almost universal in the
cohort, evidenced by the fact that all but one (participant 8; p.K485E/p.R1159W)
presented with or had a history of global developmental delay"
explanation: >-
23/24 is 96 percent, in the VERY_FREQUENT band (80-99 percent). The source names both
the count and the single exception, so the band is derived rather than estimated.
- category: Neurological
name: Intellectual Disability
description: >-
Assessed in the cohort members old enough for it - after age 5. The severity
distribution is skewed hard toward the severe end: 9 severe, 3 profound, 2 moderate, and
a single individual with none. Curated as the general term with the distribution in the
evidence rather than as four separate severity phenotypes, because the source reports
one assessment per patient across a spectrum rather than co-occurring findings.
frequency: VERY_FREQUENT
phenotype_term:
preferred_term: Intellectual disability
term:
id: HP:0001249
label: Intellectual disability
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Among cohort members assessed after age 5, 9 had severe intellectual
disability (ID), profound ID was reported for 3 individuals, moderate ID was observed
in 2 cases, and one participant (8) had no ID"
explanation: >-
14 of the 15 assessed individuals had intellectual disability, which is 93 percent and
falls in the VERY_FREQUENT band. Note the denominator is the assessed subset, not the
whole cohort - the band is over those old enough to be assessed.
- category: Neurological
name: Inability to Walk Independently
description: >-
Only 8 of 24 individuals could walk independently, and 11 of 24 could reach for and
grasp objects. Motor capability tracks two things in this cohort: it is significantly
worse in those with microcephaly, and significantly better in those with biallelic
missense variants than in those carrying a truncating allele.
frequency: FREQUENT
phenotype_term:
preferred_term: Inability to walk
term:
id: HP:0002540
label: Inability to walk
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Eight of twenty-four individuals (33%) could walk independently and 11/24
(46%) were able to reach for and grasp objects"
explanation: >-
The complement, 16/24 or 67 percent, falls in the FREQUENT band. The band is derived
from the stated count rather than quoted directly, which is why the derivation is
spelled out here.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Motor capabilities were more severely affected in those with microcephaly
(MMicro = 3.2, MNo micro = 7.2, SDMicro = 3.5, SDNo micro = 3.4, two-tailed
Mann-Whitney U, Z = −2.55, p = 0.011"
explanation: >-
Quantifies the association between microcephaly and motor outcome, which is the one
within-cohort predictor of motor severity the study reports besides variant class.
- category: Neurological
name: Seizures
description: >-
Present in 21 of 24 reported individuals. Focal to bilateral tonic-clonic is the most
common type, and most focal seizures impair awareness.
frequency: VERY_FREQUENT
phenotype_term:
preferred_term: Seizure
term:
id: HP:0001250
label: Seizure
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The phenotypes observed in more than 50% of individuals with biallelic
DENND5A variants were seizures (21/24), microcephaly (16/24), ventriculomegaly
(15/24), hypertonia (14/24), cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
explanation: >-
21/24 is 88 percent, which falls in the VERY_FREQUENT band (80-99 percent).
- category: Neurological
name: Focal to Bilateral Tonic-Clonic Seizures
description: >-
The single most frequently diagnosed seizure type in the cohort, in 9 of 24 individuals.
frequency: FREQUENT
phenotype_term:
preferred_term: Bilateral tonic-clonic seizure with focal onset
term:
id: HP:0007334
label: Bilateral tonic-clonic seizure with focal onset
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Focal to bilateral tonic-clonic is the most prominent seizure type, diagnosed
in 9 individuals"
explanation: >-
9/24 is 38 percent, in the FREQUENT band (30-79 percent).
- category: Neurological
name: Epileptic Spasms
description: >-
Reported in 6 of 24 individuals, with generalized, focal and unknown onsets all
represented.
frequency: OCCASIONAL
phenotype_term:
preferred_term: Epileptic spasm
term:
id: HP:0011097
label: Epileptic spasm
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Among the 6 individuals presenting with epileptic spasms, 3 had a generalized
onset, 2 had a focal onset, and 1 had an unknown onset"
explanation: >-
6/24 is 25 percent, in the OCCASIONAL band (5-29 percent).
- category: Neurological
name: Drug-Resistant Epilepsy
description: >-
Seizures are generally refractory. Control was achieved in only 6 of the cases, on
varied regimens, and some agents worsened seizures.
phenotype_term:
preferred_term: Refractory drug response
term:
id: HP:0020174
label: Refractory drug response
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Seizures were generally drug-resistant, but control was achieved in 6 cases
with variable antiepileptic treatment"
explanation: >-
States drug resistance as the general pattern with a minority achieving control.
- category: Neurological
name: Primary Microcephaly
description: >-
Present in 16 of 24 individuals and, in every case, primary rather than acquired - the
head was already small, consistent with a defect in prenatal neurogenesis rather than
postnatal loss. Occipitofrontal circumference percentiles varied widely across the
cohort.
frequency: FREQUENT
phenotype_term:
preferred_term: Primary microcephaly
term:
id: HP:0011451
label: Primary microcephaly
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "All cases of microcephaly in the cohort were primary, with no cases of
secondary microcephaly reported"
explanation: >-
Establishes the microcephaly as primary, which is what ties it to the prenatal
neurogenesis defect rather than to postnatal degeneration.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "seizures (21/24), microcephaly (16/24), ventriculomegaly (15/24), hypertonia
(14/24), cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
explanation: >-
16/24 is 67 percent, in the FREQUENT band (30-79 percent).
- category: Neurological
name: Ventriculomegaly
description: >-
Enlarged lateral ventricles in 15 of 24 individuals, reproduced quantitatively in the
knock-in mouse.
frequency: FREQUENT
phenotype_term:
preferred_term: Ventriculomegaly
term:
id: HP:0002119
label: Ventriculomegaly
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "microcephaly (16/24), ventriculomegaly (15/24), hypertonia (14/24), cerebral
hypoplasia (13/24), and hyperreflexia (13/24)"
explanation: >-
15/24 is 63 percent, in the FREQUENT band (30-79 percent).
- category: Neurological
name: Hypertonia
description: >-
Increased muscle tone in 14 of 24 individuals.
frequency: FREQUENT
phenotype_term:
preferred_term: Hypertonia
term:
id: HP:0001276
label: Hypertonia
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "ventriculomegaly (15/24), hypertonia (14/24), cerebral hypoplasia (13/24),
and hyperreflexia (13/24)"
explanation: >-
14/24 is 58 percent, in the FREQUENT band (30-79 percent).
- category: Neurological
name: Cerebral Hypoplasia
description: >-
Underdevelopment of cerebral structures in 13 of 24 individuals.
frequency: FREQUENT
phenotype_term:
preferred_term: Cerebral hypoplasia
term:
id: HP:0006872
label: Cerebral hypoplasia
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "hypertonia (14/24), cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
explanation: >-
13/24 is 54 percent, in the FREQUENT band (30-79 percent).
- category: Neurological
name: Hyperreflexia
description: >-
Exaggerated deep tendon reflexes in 13 of 24 individuals.
frequency: FREQUENT
phenotype_term:
preferred_term: Hyperreflexia
term:
id: HP:0001347
label: Hyperreflexia
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "cerebral hypoplasia (13/24), and hyperreflexia (13/24)"
explanation: >-
13/24 is 54 percent, in the FREQUENT band (30-79 percent).
- category: Neurological
name: Absent Speech
description: >-
15 of 24 individuals were nonverbal; a further 7 were limited to single words and only
2 could speak in sentences.
frequency: FREQUENT
phenotype_term:
preferred_term: Absent speech
term:
id: HP:0001344
label: Absent speech
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Of the individuals, 15/24 (63%) were nonverbal, 7/24 (29%) were limited to
single-word speech, and 2/24 (8%) could speak in sentences"
explanation: >-
63 percent nonverbal falls in the FREQUENT band (30-79 percent); the figure is stated
directly by the source.
- category: Neurological
name: Reduced Eye Contact
description: >-
Eye contact was present in only 11 of 24 individuals, so 13 of 24 had it reduced or
absent.
frequency: FREQUENT
phenotype_term:
preferred_term: Reduced eye contact
term:
id: HP:0000817
label: Reduced eye contact
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Eye contact was observed in 11 of 24 individuals (46%)"
explanation: >-
The complement, 13/24 or 54 percent, falls in the FREQUENT band. The band is derived
from the stated count rather than quoted directly, which is why the derivation is
spelled out here.
- category: Neurological
name: Cerebral Calcification
description: >-
Striatal, lenticulostriate and periventricular calcifications. These were part of the
original 2016 clinical description and are one of the features that brings congenital
infection into the differential diagnosis.
phenotype_term:
preferred_term: Cerebral calcification
term:
id: HP:0002514
label: Cerebral calcification
evidence:
- reference: PMID:27866705
reference_title: "Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "we have identified an epileptic encephalopathy additionally featuring
cerebral calcifications and coarse facial features"
explanation: >-
Names calcifications as part of the founding clinical description. No cohort-wide
frequency is reported for calcifications, so no frequency band is asserted.
- category: Neurological
name: Corpus Callosum Hypoplasia or Agenesis
description: >-
Corpus callosum volume in the cohort was normal, thin or absent, and never increased.
The absence of thickened tracts is a discriminating detail against the LIS1
differential.
phenotype_term:
preferred_term: Hypoplasia of the corpus callosum
term:
id: HP:0002079
label: Hypoplasia of the corpus callosum
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "In contrast, corpus callosum volumes were either normal, thin, or absent with
no cases of increased volume in our cohort"
explanation: >-
Records the callosal finding and its direction, which is what distinguishes it from
the LIS1 pattern.
- category: Neurological
name: Pachygyria
description: >-
Cortical malformation with an occipital predominance - a posterior gradient, but
without the polymicrogyria seen with OCLN variants or the dysgyria of the
tubulinopathies.
phenotype_term:
preferred_term: Pachygyria
term:
id: HP:0001302
label: Pachygyria
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "cortical malformations, particularly with pachygyria involving the occipital
lobes"
explanation: >-
Locates the cortical malformation and its posterior gradient.
- category: Craniofacial
name: Coarse Facial Features
description: >-
Part of the founding clinical description alongside the cerebral calcifications.
phenotype_term:
preferred_term: Coarse facial features
term:
id: HP:0000280
label: Coarse facial features
evidence:
- reference: PMID:27866705
reference_title: "Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "an epileptic encephalopathy additionally featuring cerebral calcifications
and coarse facial features"
explanation: >-
Names coarse facial features in the founding description.
prevalence:
- population: Worldwide
measure_type: CASES_IN_LITERATURE
prevalence_class: ULTRA_RARE
notes: >-
24 individuals from 22 families in the definitive 2024 cohort, which incorporated the
families reported earlier. No population prevalence estimate exists.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "we identified a cohort of 24 people (11F, 13M, mean age = 9.0 years, SD =
6.0) from 22 families with biallelic DENND5A variants"
explanation: >-
The total reported case count as of the 2024 study.
genetic:
- name: DENND5A
gene_term:
preferred_term: DENND5A
term:
id: hgnc:19344
label: DENND5A
relationship_type: CAUSATIVE
association: >-
Biallelic loss-of-function variants in DENND5A cause DEE49. Thirty unique variants are
reported across 22 families - 25 coding, 2 copy number and 3 splice-site - distributed
across all folded domains. Variant class is itself a severity modifier: biallelic
frameshift or nonsense variants produce significantly more neurological abnormality
than biallelic missense variants.
evidence:
- reference: PMID:27866705
reference_title: "Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "caused by recessive loss-of-function mutations in DENND5A"
explanation: >-
The gene-disease assertion.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "found that variant type influences neurological phenotype severity, with more
abnormalities in individuals with biallelic frameshift or nonsense variants (M = 7.6,
SD = 2.3) compared to those with biallelic missense variants (M = 2.8, SD = 1.6, p =
0.0004)"
explanation: >-
Quantifies variant class as a severity modifier, with the statistic.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Additionally, those with biallelic missense variants in DENND5A (M = 7.4, SD =
3.7) had significantly higher motor scores compared to those with a combination of
missense, frameshift, nonsense, intronic, or copy number variants (M = 2.9, SD = 3.0,
Kruskal-Wallis H = 7.02, p = 0.03"
explanation: >-
The parallel gradient in motor outcome across the same variant classes.
notes: >-
The recurrent missense variant R710H is the one place where a simple loss-of-function
reading is insufficient. R710H sits in the DENN-RUN1 linker and is predicted to break a
salt bridge to D598 that holds the closed conformation; experimentally it INCREASES
binding to MUPP1 and PALS1 rather than abolishing it. The gain-of-interaction and the
loss-of-protein findings are recorded here without being reconciled, because no source
available to this entry does so - see the corresponding discussion.
The deep-research report used to build this entry attributes PMID:27866705 to "Suri et
al. 2016" and PMID:39174524 to "Rodrigues et al."; the actual first authors are Han and
Banks respectively. The PMIDs themselves are correct and are what this entry cites.
diagnosis:
- name: Brain Magnetic Resonance Imaging
description: >-
Neuroimaging is how these patients reach genetic testing rather than how the diagnosis
is made. The imaging phenotype is distinctive enough to prompt a specific search -
occipital-predominant pachygyria with striatal and periventricular calcifications,
ventriculomegaly, corpus callosum agenesis or hypoplasia, basal ganglia and
diencephalic-mesencephalic junction dysplasia - but not specific enough to settle it,
since the same constellation raises OCLN-related disease, the tubulinopathies,
LIS1-related lissencephaly and congenital infection.
diagnosis_term:
preferred_term: Magnetic Resonance Imaging
term:
id: NCIT:C16809
label: Magnetic Resonance Imaging
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "These imaging studies highlight the heterogenous neuroanatomical
manifestations of biallelic DENND5A variants, but certain features including volume
loss, ventriculomegaly, and hypoplasia of the corpus callosum appear more frequently"
explanation: >-
States both what imaging reliably shows and that it is heterogeneous - the reason it
narrows the differential without closing it.
notes: >-
CT is an acceptable substitute where MRI is unavailable and was the modality in at least
one cohort member, but it is not separately curated: NCIT's CT terms describe the
procedure without the neuro qualifier that would make the entry more informative than
this one.
- name: Exome or Genome Sequencing
description: >-
The diagnosis is molecular. There is no biochemical marker and the neuroimaging
phenotype, while characteristic, overlaps enough with OCLN-related disease, the
tubulinopathies, LIS1-related lissencephaly and congenital infection that imaging alone
does not settle it.
diagnosis_term:
preferred_term: Whole Exome Sequencing
term:
id: NCIT:C101295
label: Whole Exome Sequencing
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "there is a selective involvement of the cortex added to the presence of
periventricular calcifications, a common association that brings cytomegalovirus-
induced brain malformations into the differential but aligns with pseudo-TORCH
syndrome diagnostic criteria in the absence of congenital infection"
explanation: >-
Documents the imaging differential that makes molecular confirmation necessary rather
than confirmatory.
differential_diagnoses:
- name: Pseudo-TORCH syndrome and OCLN-related band-like calcification
disease_term:
preferred_term: pseudo-TORCH syndrome
term:
id: MONDO:0009626
label: pseudo-TORCH syndrome
description: >-
The closest mechanistic mimic, and not by coincidence. OCLN encodes the tight-junction
protein occludin, and recessive OCLN variants cause a DEE through a defect in the same
process this disorder disrupts - neural progenitor symmetric cell division, there via
impaired mitotic spindle formation and centrosome misalignment. The imaging converges
too: cortical migration abnormalities plus calcifications.
distinguishing_features:
- >-
Polymicrogyria is a key feature of OCLN variants and is not seen in the DENND5A cohort,
which shows occipital pachygyria instead.
- >-
Severe basal ganglia dysplasia and diencephalic-mesencephalic junction dysplasia are
reported in DENND5A and were not reported with OCLN.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Cortical migration abnormalities and calcifications are observed in cases with
recessive variants in the tight junction protein-encoding OCLN gene, but severe basal
ganglia or diencephalic and mesencephalic dysplasias were not reported and
polymicrogyria, a key feature of OCLN mutations, is not observed in our study"
explanation: >-
States both the overlap and the two features that separate them.
- name: Congenital cytomegalovirus infection
disease_term:
preferred_term: fetal cytomegalovirus syndrome
term:
id: MONDO:0017409
label: fetal cytomegalovirus syndrome
description: >-
The differential a clinician actually faces first. Periventricular calcifications with
selective cortical involvement is a classic congenital-infection pattern, and the
DENND5A imaging phenotype reproduces it closely enough that the paper names the
confusion explicitly.
distinguishing_features:
- >-
Absence of congenital infection on serology or PCR. The same constellation then aligns
with pseudo-TORCH diagnostic criteria - which is to say, with a genetic rather than an
infectious cause.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "there is a selective involvement of the cortex added to the presence of
periventricular calcifications, a common association that brings cytomegalovirus-
induced brain malformations into the differential but aligns with pseudo-TORCH
syndrome diagnostic criteria in the absence of congenital infection"
explanation: >-
Names congenital CMV as the differential the imaging raises, and the finding that
resolves it.
- name: LIS1-related lissencephaly
description: >-
LIS1 encodes a neuronal migration protein and produces a posterior gradient of
lissencephaly - the same posterior-predominant direction as the DENND5A pachygyria,
which is what makes it a live differential rather than a distant one.
distinguishing_features:
- >-
Calcifications are absent in LIS1-related lissencephaly and present in DENND5A.
- >-
Corpus callosum size in LIS1 varies in both directions, including thicker than normal;
in the DENND5A cohort it was normal, thin or absent with no case of increased volume.
The directionality of the callosal finding, not merely its presence, is the
discriminator.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Variants in LIS1, encoding a protein involved in neuronal migration, results
most frequently in a posterior gradient of lissencephaly, without calcifications, and
variable degrees of corpus callosum size including thin, normal, and thicker than
normal tracts"
explanation: >-
Gives both distinguishing features - the absent calcifications and the bidirectional
callosal variation.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "In contrast, corpus callosum volumes were either normal, thin, or absent with
no cases of increased volume in our cohort"
explanation: >-
The DENND5A side of the callosal contrast.
notes: >-
No disease_term is bound. MONDO has no single term for LIS1-related lissencephaly as a
class - the relevant concepts are gene- and syndrome-specific (Miller-Dieker, isolated
lissencephaly sequence) and the source speaks of "variants in LIS1" generally, so
binding any one of them would narrow the claim beyond what is written.
- name: Tubulinopathies
description: >-
Tubulin gene variants produce overlapping cortical malformation phenotypes and belong in
the same imaging differential.
distinguishing_features:
- >-
The tubulinopathies show a classic dysgyria pattern that the DENND5A cohort lacks.
- >-
The tubulinopathies are not associated with calcifications, which are present in
DENND5A.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Variants in tubulin genes also result in overlapping phenotypes47, but our
cases lack the classic dysgyria pattern and instead are observed in the context of
occipital pachygyria and differ in that our cases are associated with calcifications"
explanation: >-
States the overlap and both discriminating features.
notes: >-
No disease_term is bound: "tubulinopathies" names a gene-family grouping (TUBA1A, TUBB2B,
TUBB3 and others) rather than one MONDO concept, and the source refers to the class.
treatments:
- name: Antiseizure Medication
description: >-
Management is symptomatic. No agent has disease-specific efficacy evidence, seizures
are generally drug-resistant, and the cohort record includes agents that worsened
seizures as well as agents that helped - phenytoin and lamotrigine each worsened
seizures in one individual. Levetiracetam and sodium valproate were the most commonly
reported agents achieving control.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: levetiracetam
term:
id: CHEBI:6437
label: levetiracetam
- preferred_term: valproic acid
term:
id: CHEBI:39867
label: valproic acid
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Seizures were generally drug-resistant, but control was achieved in 6 cases
with variable antiepileptic treatment. Anti-seizure medications variably helped, did
not affect, or worsened seizures"
explanation: >-
Curated PARTIAL: it records a mixed and often unsuccessful response, not an effective
treatment. The explicit inclusion of worsening is why this cannot be read as support
for antiseizure medication as such.
notes: >-
The mechanism gives no obvious therapeutic handle. The rate-limiting defect - spindle
misorientation in apical progenitors - occurs during prenatal neurogenesis and is
complete before the disorder presents, so a treatment aimed at the mechanism would have
to act on a window that has closed by the time of diagnosis. This is a structural
limitation of the disorder, not a gap in the drug literature.
- name: Genetic Counseling
description: >-
Autosomal recessive with a 25 percent recurrence risk per pregnancy for carrier
couples. Consanguinity was a feature of the founding families, which is the standard
context for identifying biallelic rare-variant disease.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: Genetic Counseling
term:
id: NCIT:C15240
label: Genetic Counseling
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "For families in which one parent is aware they are a carrier of a pathogenic
DENND5A variant, genetic counselors can recommend the other parent undergo genetic
testing. When both parents are carriers, in vitro fertilization with preimplantation
genetic diagnosis can be offered"
explanation: >-
Names genetic counselors, carrier testing of the second parent, and IVF with
preimplantation genetic diagnosis - the reproductive options this treatment entry
asserts. This replaces an earlier quote that was the paper's generic closing sentence
about being clinically informative, which did not state any of it.
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "the presence of DENND5A VUSs does not necessarily equate to a devastating
prognosis; 13% (3 cases) of our small cohort did not meet criteria for DEE or
experience seizures at the time of data collection"
explanation: >-
Curated PARTIAL because it qualifies rather than supports: the counseling message is
not uniformly severe. This is the same 3 of 24 recorded on the seizure endpoint node,
and it is the counseling-relevant reading of that number.
animal_models:
- name: DENND5A knock-in mouse
species: Mouse
genotype: homozygous DENND5A knock-in (no full-length protein expressed)
publication: PMID:39174524
description: >-
A knock-in line in which full-length DENND5A protein is not expressed. Used for
structural neuroimaging, adult subventricular zone histology and chemically provoked
seizure susceptibility.
modeled_mechanisms:
- target: Compensatory Ventriculomegaly
relationship: RECAPITULATES
fidelity: HIGH
limitations: >-
Ventricular volume was measured in adults; the model does not report the
developmental time course by which the enlargement arises, so it corroborates the
endpoint rather than the compensatory interpretation placed on it.
description: >-
In vivo 7T MRI reproduces the human ventriculomegaly.
readouts:
- name: Lateral ventricle volume
target: Compensatory Ventriculomegaly
direction: INCREASED
interpretation: >-
Significantly enlarged lateral ventricles in knock-in mice.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "DENND5A KI mice have significantly enlarged lateral ventricles (MWT = 4.8
mm3, MKI = 6.6 mm3, SDWT = 1.3, SDKI = 2.4, two-tailed Mann-Whitney U, Z =
−2.117, p = 0.034)"
explanation: >-
The quantitative volumetric measurement.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "In vivo 7T MRI scans revealed that DENND5A KI mice have significantly
enlarged lateral ventricles"
explanation: >-
Supports treating the mouse as informative for the human ventriculomegaly.
- target: Premature Neuronal Differentiation and Cell Cycle Exit
relationship: RECAPITULATES
fidelity: MODERATE
limitations: >-
Measured in the adult subventricular zone, not the embryonic ventricular zone where
the disorder's neurogenesis defect is proposed to occur. Adult SVZ neurogenesis is a
different process from cortical neurogenesis, so this is a corroborating observation
in an analogous niche rather than a direct test of the developmental claim.
description: >-
A higher proportion of post-mitotic neurons in the adult neurogenic niche.
readouts:
- name: NeuN-positive post-mitotic neurons in the subventricular zone
target: Premature Neuronal Differentiation and Cell Cycle Exit
direction: INCREASED
interpretation: >-
Knock-in mice have proportionally more post-mitotic neurons, consistent with
progenitors exiting the cycle.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "KI mice have a significantly higher percentage of post-mitotic neurons
expressing NeuN compared to WT mice"
explanation: >-
The histological measurement behind this readout.
- name: GFAP-positive stem-like cells in the subventricular zone
target: Premature Neuronal Differentiation and Cell Cycle Exit
direction: UNCHANGED
interpretation: >-
A real negative result, retained rather than dropped. The expected reciprocal fall
in the GFAP-positive stem-like population was present in the mean but did not reach
significance, so the stem-cell-depletion half of the model is not demonstrated in
this assay even though the neuronal half is.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "While there is also a reduction in the mean proportion of GFAP-positive
cells in the SVZ of the KI mice, it did not reach significance"
explanation: >-
The non-significant measurement, stated directly by the source.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "we used our DENND5A KI mice to examine the adult subventricular zone (SVZ),
a region that normally retains GFAP-positive RG-like neural stem cells"
explanation: >-
Establishes what niche was examined and why it was chosen as an analogue.
- target: Seizure Generation and Developmental and Epileptic Encephalopathy
relationship: PARTIALLY_RECAPITULATES
fidelity: MODERATE
limitations: >-
The mice do not have spontaneous seizures. What is measured is a lowered threshold to
a chemoconvulsant, 4-aminopyridine, which is a susceptibility phenotype and not
epilepsy. The human disorder is defined by recurrent unprovoked seizures, so this is
the weakest correspondence in the model.
description: >-
Increased chemoconvulsant seizure susceptibility without spontaneous seizures.
readouts:
- name: Latency to seizure after 4-aminopyridine
target: Seizure Generation and Developmental and Epileptic Encephalopathy
direction: DECREASED
interpretation: >-
Knock-in mice seize sooner after 4-AP than wild-type, indicating a lowered seizure
threshold.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "they show increased seizure susceptibility compared to WT when
administered the potassium channel blocker 4-aminopyridine (MWT = 23.60, MKI =
11.67, SDWT = 2.97, SDKI = 7.20, two-tailed t(9) = 3.445, p = 0.007"
explanation: >-
The latency measurement behind this readout.
- name: Spontaneous seizures
target: Seizure Generation and Developmental and Epileptic Encephalopathy
direction: UNCHANGED
interpretation: >-
A real negative result. No spontaneous seizures were observed, which is why the
relationship is PARTIALLY_RECAPITULATES rather than RECAPITULATES.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "while spontaneous seizures were not observed in the KI mice, they show
increased seizure susceptibility compared to WT"
explanation: >-
The source's own statement that the spontaneous phenotype is absent.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Finally, while spontaneous seizures were not observed in the KI mice, they
show increased seizure susceptibility compared to WT"
explanation: >-
Curated PARTIAL because the model captures threshold, not the recurrent unprovoked
seizures that define the human disorder.
- target: Reduced Brain Volume and Cortical Malformation
relationship: FAILS_TO_RECAPITULATE
fidelity: LOW
limitations: >-
Relative brain size was lower in mean and median but the difference did not reach
statistical significance, with high variability. The authors note the same
variability in human occipitofrontal circumference, so the failure may reflect the
trait's variance rather than an absent phenotype - but as measured, the mouse does not
demonstrate reduced brain size, and this entry does not report it as though it did.
description: >-
The microcephaly phenotype is not statistically reproduced in the mouse.
readouts:
- name: Relative brain size
target: Reduced Brain Volume and Cortical Malformation
direction: UNCHANGED
interpretation: >-
Lower in mean and median but not significantly so.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: REFUTE
evidence_source: MODEL_ORGANISM
snippet: "KI mice also have a lower mean and median relative brain sizes, but like
the human cohort in which occipitofrontal circumference percentiles varied
considerably, a high degree of variability was observed in the mice and the
difference did not reach statistical significance"
explanation: >-
Curated REFUTE for this specific readout: the measurement does not support a
reduced brain size in this model, and the source says so directly.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: REFUTE
evidence_source: MODEL_ORGANISM
snippet: "a high degree of variability was observed in the mice and the difference did
not reach statistical significance"
explanation: >-
The negative result that requires this link to be curated as
FAILS_TO_RECAPITULATE.
- name: dennd5a F0 CRISPR knockout zebrafish
species: Zebrafish
genotype: biallelic dennd5a CRISPR/Cas9 F0 knockout (crispant)
publication: PMID:39174524
description: >-
F0 crispants carrying biallelic dennd5a mutations, phenotyped morphologically at 5 days
post fertilization. The value of this model is that it reproduces the two structural
findings - small head, large ventricle - in a second species and at a whole-organism
developmental scale.
modeled_mechanisms:
- target: Reduced Brain Volume and Cortical Malformation
relationship: RECAPITULATES
fidelity: MODERATE
limitations: >-
F0 crispants are genetic mosaics, so the penetrance of the biallelic state varies
between and within animals. Head size in a larval zebrafish is a coarse proxy for
human microcephaly, and the zebrafish brain has no cortex, so the cortical
malformation component of this node cannot be modeled here at all.
description: >-
Reduced head size and enlarged ventricle in the knockout larvae.
readouts:
- name: Head size
target: Reduced Brain Volume and Cortical Malformation
direction: DECREASED
interpretation: >-
Reduced head size in F0 knockouts, the cross-species correlate of microcephaly.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "F0 KOs show structural and behavioral perturbations consistent with
DENND5A-related DEE including reduced head size and increased ventricle size"
explanation: >-
The morphological measurements behind this readout.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Biallelic mutations in dennd5a were introduced into zebrafish larvae using
CRISPR/Cas9 (F0 KOs)"
explanation: >-
Establishes the model as a biallelic knockout matching the human genotype.
experimental_models:
- name: DENND5A knockout human iPSC-derived neural rosettes
experimental_model_type: IPSC_DERIVED_MODEL
description: >-
Neural rosettes formed from wild-type and CRISPR/Cas9 DENND5A knockout human iPSCs. A
rosette is a polarized in vitro model of early neural development with a central
F-actin-rich lumen standing in for the ventricular surface, which is what makes the
mitotic spindle angle measurable at all. This is the system that produced the
disorder's central quantitative finding.
publication: PMID:39174524
modeled_mechanisms:
- target: Mitotic Spindle Misorientation in Apical Neural Progenitors
relationship: RECAPITULATES
fidelity: HIGH
limitations: >-
Human but not patient-derived: the knockout is engineered, so the model tests the
consequence of absent DENND5A rather than of any particular patient allele. The
spindle-angle measurement also required excluding cells whose chromatin was
abnormally condensed - a class over-represented in the knockouts - so the reported
angle distribution is drawn from the subset of knockout divisions that looked
normal enough to measure.
description: >-
Direct quantification of mitotic spindle angle relative to the apical surface.
readouts:
- name: Mitotic spindle angle relative to the apical surface
target: Mitotic Spindle Misorientation in Apical Neural Progenitors
direction: DECREASED
interpretation: >-
Knockout progenitors divide at a much shallower angle to the apical surface than
wild-type, and most fall below the 45 degree line that separates symmetric from
oblique division.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "the spindle angle among cells dividing within WT (M = 57.1°, Mdn = 65.4°,
SD = 25.9) and KO (M = 26.0°, Mdn = 20.1°, SD = 19.0) rosettes differed
significantly"
explanation: >-
The quantitative angle measurement.
- name: Apical localization of PALS1
target: Mitotic Spindle Misorientation in Apical Neural Progenitors
direction: UNCHANGED
interpretation: >-
A real negative result that constrains the mechanism. PALS1 still reaches the apical
membrane without DENND5A, so DENND5A is not required to traffic the polarity complex
there - which is why the edge from the interaction node to this one is curated with
unknown intermediates rather than as a direct trafficking failure.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "PALS1 localized apically in both WT and KO rosettes (Supplementary Fig.
5f), suggesting DENND5A is not involved in trafficking MUPP1/PALS1 to the apical
membrane"
explanation: >-
The negative localization result, stated directly by the source.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "We performed a neural rosette formation assay, a polarized in vitro model of
early neural development, to examine for potential alterations in the symmetry of
cell division following loss of DENND5A"
explanation: >-
Establishes the model and what it was used to measure.
- name: DENND5A knockout human iPSC-derived neural progenitor cells
experimental_model_type: IPSC_DERIVED_MODEL
description: >-
Neural progenitors differentiated from wild-type and DENND5A knockout human iPSCs,
validated as SOX1, SOX2 and Nestin positive. Used for proliferation counts and for the
premature differentiation assay.
publication: PMID:39174524
modeled_mechanisms:
- target: Neural Progenitor Pool Depletion
relationship: RECAPITULATES
fidelity: HIGH
limitations: >-
Part of the day-one difference is attributed by the authors to increased apoptosis in
knockout cells after plating rather than to slower division, so the proliferation
deficit and a survival deficit are not fully separated in this assay.
description: >-
Knockout progenitors fail to expand.
readouts:
- name: Neural progenitor cell number over 72 hours
target: Neural Progenitor Pool Depletion
direction: DECREASED
interpretation: >-
Wild-type progenitors expand while knockouts stay nearly flat, with the gap widening
from 48 to 72 hours.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "We observed that DENND5A KO NPCs grow slower than WT"
explanation: >-
The proliferation measurement behind this readout.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "NPCs express SOX1, SOX2, and Nestin, affirming their NPC identity"
explanation: >-
Establishes the identity of the cells used, which is what makes the proliferation
claim about progenitors rather than about mixed culture.
- target: Premature Neuronal Differentiation and Cell Cycle Exit
relationship: RECAPITULATES
fidelity: HIGH
limitations: >-
The assay reports the proportion of cells with neuronal morphology and beta-III
tubulin staining after one day, not a full differentiation trajectory or a subtype
assignment, so it establishes that the cells commit early without saying what they
commit to.
description: >-
Knockout progenitors develop neuronal processes under conditions meant to keep them
undifferentiated.
readouts:
- name: Proportion of beta-III tubulin-positive cells in maintenance medium
target: Premature Neuronal Differentiation and Cell Cycle Exit
direction: INCREASED
interpretation: >-
47.29 percent of knockout cells against 10.67 percent of wild-type, one day after
passage into progenitor maintenance medium.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Our results suggest that DENND5A expression promotes stemness and its loss
drives cell cycle exit and premature differentiation into neuronal phenotypes"
explanation: >-
The authors' statement of what the differentiation measurements show.
evidence:
- reference: PMID:39174524
reference_title: "Loss of symmetric cell division of apical neural progenitors drives DENND5A-related developmental and epileptic encephalopathy."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Human induced pluripotent stem cells lacking DENND5A fail to undergo
symmetric cell division with an inherent propensity to differentiate into neurons"
explanation: >-
Supports treating the knockout iPSC system as informative for the differentiation
node.
discussions:
- discussion_id: controversy_r710h_gain_of_interaction_versus_loss_of_function
kind: CONTROVERSY
status: OPEN
attaches_to:
- pathophysiology#Reduced DENND5A Protein
- pathophysiology#Loss of DENND5A-MUPP1/PALS1 Association at the Apical Membrane
prompt: >-
If the disorder is caused by loss of DENND5A function, how does a recurrent variant
that INCREASES binding to the polarity complex cause it?
rationale: >-
The two findings sit in direct tension and the entry does not smooth them. Every
patient-derived cell line shows reduced DENND5A protein, and the population genetics
support a recessive loss-of-function model. Yet R710H, a recurrent cohort variant, lies
in the DENN-RUN1 linker where it is predicted to break a salt bridge holding the closed
conformation, and introducing it experimentally increases binding to MUPP1 and PALS1.
A protein locked open would engage the polarity complex more, not less. Three readings
are available and none is excluded. The variant may be destabilizing in cells, so that
reduced abundance overrides increased per-molecule affinity - the R710H individual in
the cohort is compound heterozygous, which would matter here. Or the closed
conformation may be functionally required - if DENND5A must cycle between a Rab-binding
RUN1-exposed state and a polarity-binding open state, then constitutive opening is a
loss of function even though it looks like a gain of binding. Or the polarity
interaction may not be the arm through which R710H acts at all. Which reading is right
determines whether R710H should be curated as a distinct mechanistic class within DEE49.
proposed_experiments:
- experiment_id: exp_r710h_abundance_and_spindle_angle
name: R710H knock-in iPSC rosettes with matched abundance measurement
description: >-
Introduce R710H as a knock-in into wild-type human iPSCs and measure both DENND5A
protein abundance and mitotic spindle angle in the resulting rosettes, against
wild-type and full knockout. If R710H reduces abundance and misorients spindles, it is
a loss-of-function allele whose binding gain is irrelevant in cells. If abundance is
preserved and spindles are still misoriented, the closed conformation is functionally
required and constitutive opening is itself the lesion.
- discussion_id: gap_route_from_polarity_complex_to_spindle_angle
kind: KNOWLEDGE_GAP
status: OPEN
attaches_to:
- pathophysiology#Loss of DENND5A-MUPP1/PALS1 Association at the Apical Membrane
- pathophysiology#Mitotic Spindle Misorientation in Apical Neural Progenitors
prompt: >-
By what molecular route does losing the DENND5A-MUPP1/PALS1 interaction change the
orientation of the mitotic spindle?
rationale: >-
This is the entry's central unexplained step, and the obvious explanation has been
tested and excluded. If DENND5A were required to deliver the polarity proteins to the
apical membrane, their mislocalization would explain the spindle defect - but PALS1
localizes apically in knockout rosettes just as it does in wild-type, and the authors
state directly that DENND5A is not involved in that trafficking. Something else
therefore connects the interaction to spindle positioning: an effect on the astral
microtubule capture machinery, on centrosome anchoring, on the local apical actin
cortex, or an entirely separate DENND5A function. Without this step the disease model
holds together descriptively but not mechanistically, and the edge is curated
INDIRECT_UNKNOWN_INTERMEDIATES for exactly that reason.
proposed_experiments:
- experiment_id: exp_spindle_anchoring_machinery_in_dennd5a_ko
name: Astral microtubule and cortical anchoring machinery in DENND5A knockout rosettes
description: >-
Image the LGN-NuMA-dynein cortical anchoring complex and astral microtubule contacts
at the apical cortex of dividing wild-type and DENND5A knockout rosette progenitors,
and test whether DENND5A or MUPP1/PALS1 co-localizes with or is required for that
complex. A defect in cortical anchoring would supply the missing step; its absence
would redirect the search toward centrosome positioning.
- discussion_id: gap_evidence_for_the_seizure_step
kind: KNOWLEDGE_GAP
status: OPEN
attaches_to:
- pathophysiology#Aberrant Positioning and Connectivity of Prematurely Born Neurons
- pathophysiology#Seizure Generation and Developmental and Epileptic Encephalopathy
prompt: >-
What actually makes DENND5A-deficient brain seize?
rationale: >-
The disorder is classified as a developmental and epileptic encephalopathy, and the
developmental half is well evidenced down to quantitative spindle angles. The epileptic
half is not. The proposed route - prematurely born neurons sitting in the wrong place
and forming aberrant synaptic contacts - appears in the authors' disease model and is
curated PARTIAL here because no measurement supports it: no source available to this
entry reports excitation-inhibition balance, network synchrony, intrinsic excitability
or synaptic physiology in DENND5A-deficient neurons. The mouse contributes threshold
data only, and no spontaneous seizures. This is why this entry conforms to the epilepsy
module at the clinical Recurrent Unprovoked Seizures endpoint rather than at the
excitation-inhibition or hyperexcitability nodes: attaching upstream would let the
module supply a mechanistic claim the evidence does not make. The authors themselves
note that identifying whether excitatory or inhibitory neurons are disproportionately
affected would help clinicians choose an antiseizure medication, which makes this gap
clinically live rather than merely descriptive.
proposed_experiments:
- experiment_id: exp_excitatory_inhibitory_balance_in_dennd5a_deficient_cortex
name: Excitatory and inhibitory neuron census and network physiology in DENND5A knockout
description: >-
Quantify excitatory and inhibitory neuron subpopulations across cortical layers in
DENND5A knock-in mouse cortex at several developmental timepoints, and record network
activity from DENND5A knockout human iPSC-derived neuronal cultures on multielectrode
arrays. This tests whether the premature differentiation is subtype-biased and whether
the resulting network is intrinsically hyperexcitable, which would convert the
entry's inferential seizure step into a measured one.
- discussion_id: gap_which_progenitor_stage_is_primarily_affected
kind: KNOWLEDGE_GAP
status: OPEN
attaches_to:
- pathophysiology#Mitotic Spindle Misorientation in Apical Neural Progenitors
prompt: >-
Is the defect primarily in neuroepithelial cells or in apical radial glia?
rationale: >-
The two progenitor stages differ in junctional composition - neuroepithelial cells have
tight junctions, radial glia rely on adherens junctions - and MUPP1 is reported to
preferentially stabilize adherens junctions over tight junctions. The authors take that
asymmetry to predict a radial-glia-specific defect, but the prediction has not been
tested: the rosette assay does not resolve the two stages, and the mouse data come from
the adult subventricular zone rather than the embryonic ventricular zone. Which stage is
affected sets the developmental window and hence what a hypothetical intervention would
have to reach.
proposed_experiments:
- experiment_id: exp_stage_resolved_spindle_angles_in_vivo
name: Stage-resolved spindle angle measurement in the embryonic mouse ventricular zone
description: >-
Measure mitotic spindle angles of dividing apical progenitors in the DENND5A knock-in
mouse ventricular zone across the neuroepithelial-to-radial-glia transition, with
stage markers, and quantify progenitor and post-mitotic proportions at each timepoint.
This is the experiment the authors themselves propose, and it would establish both the
affected stage and whether the in vivo spindle defect matches the rosette measurement.
- discussion_id: mismatch_adult_svz_as_proxy_for_embryonic_neurogenesis
kind: HUMAN_MODEL_MISMATCH
status: OPEN
attaches_to:
- pathophysiology#Premature Neuronal Differentiation and Cell Cycle Exit
- pathophysiology#Shortened Period of Neurogenesis
prompt: >-
Does increased neuronal differentiation in the adult mouse subventricular zone speak to
a defect in human embryonic cortical neurogenesis?
rationale: >-
The in vivo evidence for premature differentiation comes from the adult subventricular
zone, while the disease model is about embryonic cortical neurogenesis. These are
different niches with different progenitors, different output lineages and different
regulatory logic; adult SVZ neurogenesis produces olfactory bulb interneurons in mouse
and is of contested extent in adult humans at all. The authors chose the niche because
it retains GFAP-positive radial-glia-like stem cells, which is a reasonable analogy, but
an analogy is what it is. Compounding this, the mouse fails to reproduce the
microcephaly that the embryonic defect is supposed to cause - relative brain size was
lower but not significantly so. The human iPSC rosette and progenitor data carry the
developmental claim; the mouse SVZ result corroborates it in an adjacent system and
should not be read as confirming it in the relevant one.
proposed_experiments:
- experiment_id: exp_embryonic_vz_differentiation_timecourse
name: Embryonic ventricular zone progenitor and neuron census across neurogenesis
description: >-
Quantify progenitor and post-mitotic neuron proportions in the DENND5A knock-in mouse
embryonic ventricular and subventricular zones across the full neurogenic period, and
compare the trajectory to wild-type. If the premature-differentiation shift is present
embryonically and cortically, the adult SVZ result becomes corroboration rather than
the primary in vivo evidence; if it is absent, the mouse does not model the human
developmental mechanism and the microcephaly failure is explained.
notes: >-
Scope: this entry curates DEE49, the autosomal recessive disorder caused by biallelic
DENND5A variants. Heterozygous DENND5A loss-of-function variants are separately reported
to predispose to familial cutaneous melanoma through an SNX1-related trafficking deficit;
that is a different disorder with a different mode of inheritance and is not modeled here.
Evidence base. Two primary sources: the 2016 founding report (PMID:27866705, abstract
only in the reference cache) and the 2024 Nature Communications cohort and mechanism study
(PMID:39174524, full text). All snippets are quoted from those cached records. The
quantitative figures in the pathophysiology descriptions - spindle angles, cell counts,
differentiation percentages - come from the 2024 full text; where a figure appears in a
description rather than in a snippet it is because the source sentence carrying it also
carries statistical notation that does not quote cleanly.
A third reference proposed by the deep-research report, PMID:27431290 (Anazi et al. 2017),
was fetched and then not used: it is a broad intellectual-disability genomics paper whose
retrievable abstract does not mention DENND5A, so it cannot support any DENND5A-specific
claim quoted from it. The report also cites PMID:38352438, the medRxiv preprint of the
same 2024 study; the published version is cited instead.
Hypotonia is deliberately not curated. It appears in the research report from the OMIM
clinical synopsis rather than from either primary source, and neither cached paper states
it in a form that could be quoted. The cohort's own motor findings - 8 of 24 walking
independently, 11 of 24 able to grasp - are curated instead, since those are counted in
the source. If a future curator adds hypotonia it should come with a primary citation, not
from the synopsis.
Ontology terms proposed by the deep-research report and rejected after checking against
OAK: GO:0051654 was proposed for spindle localization but is "establishment of
mitochondrion localization"; CL:0002608 was proposed for radial glial cell but is
"hippocampal neuron"; CL:0000060 was proposed for neural progenitor cell but is
"odontoblast". The correct terms used here are GO:0000132, CL:0000681 and CL:0011020.
The Crumbs complex is left unbound: GO:0035003 subapical complex is defined for
invertebrate epithelia and there is no vertebrate Crumbs complex term, so the protein
complex carries a free-text preferred_term only.
Overview. DENND5A-related developmental and epileptic encephalopathy (also designated Developmental and Epileptic Encephalopathy 49, DEE49) is a severe, autosomal recessive neurodevelopmental disorder caused by biallelic loss-of-function (or partial loss-of-function) variants in DENND5A. It belongs to the broader clinical/genetic category of "epileptic encephalopathies" — catastrophic infantile-onset epilepsies with refractory seizures and cognitive arrest that are usually attributable to abnormal brain development rather than solely to the seizures themselves. The original description states: "Epileptic encephalopathies are a catastrophic group of epilepsies characterized by refractory seizures and cognitive arrest, often resulting from abnormal brain development. Here, we have identified an epileptic encephalopathy additionally featuring cerebral calcifications and coarse facial features caused by recessive loss-of-function mutations in DENND5A" (Suri et al., 2016, PMID: 27866705).
Key identifiers: - OMIM disease entry: #617281 — Developmental and Epileptic Encephalopathy 49 (DEE49) - OMIM gene entry: 617278 — DENN Domain-Containing Protein 5A (DENND5A) - HGNC: HGNC:19344 - NCBI Gene ID: 23258 - Cytogenetic location: 11p15.4 (chromosome 11) - Orphanet: DENND5A is included on the Orphanet "Molecular diagnosis of Epileptic Encephalopathy" gene panel (EPI02v17.1) and the "Molecular diagnosis of Fetal Akinesia" gene panel; a disease-specific ORPHA number search returned an unreliable/unconfirmed value in secondary sources during this research (candidate ORPHA:1934 could not be independently verified against Orphanet's own disorder pages and should be confirmed directly at orpha.net before use). - MONDO: Not confirmed via direct Mondo lookup during this research; should be cross-referenced against the OMIM #617281 xref. - NIH Genetic Testing Registry (GTR): condition C4310635 ("Developmental and epileptic encephalopathy, 49") - Related umbrella:* ILAE Developmental and Epileptic Encephalopathy (DEE) nosology
Synonyms/alternative names: - Developmental and Epileptic Encephalopathy 49 (DEE49) - Epileptic Encephalopathy, Early Infantile, 49 (EIEE49) — the pre-2020 ILAE nomenclature used in earlier OMIM/literature entries (e.g., Anazi et al. 2017 refers to "EIEE49") - DENND5A deficiency
Evidence basis. The disease is characterized almost entirely from aggregated, disease-level resources built from case series/cohort studies (not large-scale EHR data): the founding 2016 report of 2 families (4 affected individuals) (PMID:27866705), a 2017 exome-sequencing cohort report identifying 2 additional patients (Anazi et al., PMID:27431290), and the definitive natural-history/mechanism cohort study that expanded the total reported cohort to 23–24 individuals from 21–22 families with 30 unique variants (Rodrigues et al., Nature Communications 2024, PMID: 39174524; preprint PMID:38352438 on medRxiv).
Disease causal factor: Purely genetic/Mendelian. DEE49 is caused by biallelic (homozygous or compound heterozygous) pathogenic variants in DENND5A — there is no known environmental, infectious, or acquired etiology described in the literature.
None reported. No toxin, occupational, infectious, or lifestyle exposure has been associated with DEE49 causation; this is consistent with its status as a monogenic recessive disorder.
None specifically documented. No protective genetic modifier or environmental protective factor has been reported in the literature to date.
Not applicable/not reported — no evidence of gene-environment interaction has been described for this monogenic disorder.
Phenotype frequency data below are drawn from the 2024 Nature Communications natural-history cohort (Rodrigues et al., PMID:39174524; n = 24 individuals, 11 female/13 male, mean age 9.0 years, from 22 families), supplemented by the original OMIM clinical synopsis (#617281) and the 2016/2017 case reports.
| Phenotype | Frequency | Notes / HPO term suggestion |
|---|---|---|
| Global developmental delay / intellectual disability | 23/24 (96%) | Near-universal; HP:0001263 (Global developmental delay), HP:0001249 (Intellectual disability) |
| Seizures | 21/24 (87.5%) | Mean onset 4.8 months (range includes neonatal onset per OMIM); focal-to-bilateral tonic-clonic most common. HP:0001250 (Seizure), HP:0032792 (Neonatal onset seizure), HP:0002007 (Frontal release signs — not applicable; use HP:0032917 Bilateral tonic-clonic seizure with focal onset if precise typing needed) |
| Microcephaly | 16/24 (67%) | Primary/congenital in many cases; OFC percentile highly variable. HP:0000252 (Microcephaly) |
| Ventriculomegaly | 15/24 (63%) | Often with normal head circumference (dissociates from microcephaly). HP:0002119 (Ventriculomegaly) |
| Hypertonia / spasticity | 14/24 (58%) | HP:0001276 (Hypertonia), HP:0001257 (Spasticity) — note OMIM synopsis lists hypotonia as well; tone findings can evolve from early hypotonia to later spasticity |
| Hypotonia | Reported in OMIM synopsis (majority) | HP:0001252 (Hypotonia) |
| Cerebral hypoplasia / reduced brain volume | 13/24 (54%) | Gray/white matter volume reduction on MRI. HP:0006872 (Cerebral hypoplasia) |
| Hyperreflexia | 13/24 (54%) | HP:0001347 (Hyperreflexia) |
| Nonverbal status / absent speech | 15/24 (63%) | HP:0001344 or HP:0002465 (Absent speech) |
| Corpus callosum dysgenesis/agenesis/hypoplasia | Multiple cases (documented in both 2016 and 2024 series) | HP:0002079 (Hypoplasia of the corpus callosum) / HP:0001274 (Agenesis of corpus callosum) |
| Brain (basal ganglia/periventricular/diencephalic) calcifications | Multiple cases, including the original 2 sisters | HP:0002514 (Basal ganglia calcification) / HP:0030955 (Cerebral calcification) |
| Coarse facial features | All 4 original affected individuals, and additional cohort members | HP:0000280 (Coarse facial features) |
| Specific facial features: open mouth, tented full upper lip, thick everted lower lip, short philtrum, large nostrils | Documented in original family | HP:0000212 (Tented upper lip vermilion), HP:0000232 (Everted lower lip vermilion), HP:0000322 (Short philtrum), HP:0000463 (Anteverted nares/large nostrils) |
| Frontal bossing | Per OMIM clinical synopsis | HP:0002007 — actually HP:0011220 (Frontal bossing) |
| Dandy-Walker malformation / posterior fossa cyst / hypoplastic vermis / diffuse hydrocephalus | Subset of cases | HP:0001305 (Dandy-Walker malformation), HP:0002365 (Poor head control) — use HP:0007360 (Aplasia/Hypoplasia of the cerebellar vermis) |
| Intellectual disability severity | Severe (9), profound (3), moderate (2) of characterized subset | Severity spectrum — HP:0010864 (Severe ID), HP:0002187 (Profound ID) |
Age of onset: Neonatal-to-infantile. OMIM's clinical synopsis specifically notes "onset of seizures in the neonatal period" for the classic/severe presentation; the broader 2024 cohort reports mean seizure onset at 4.8 months (i.e., early infantile more often than strictly neonatal), reflecting phenotypic heterogeneity linked to variant type.
Severity and progression: Presentation ranges from a severe, classic DEE49 phenotype (neonatal/early-infantile refractory seizures, profound global developmental delay, absent speech, microcephaly, spasticity, coarse facies, and brain calcifications) to milder phenotypes without seizures or with normal neuroimaging in individuals carrying specific missense/hypomorphic variant combinations. The disease course is generally progressive/static-severe rather than degenerative — the core insult (impaired neurogenesis in utero) is developmental, but epilepsy itself can be refractory and lifelong, and developmental impairment is lifelong.
Quality of life impact: Not formally measured with standardized instruments (e.g., no EQ-5D/PROMIS data identified in the literature). Qualitatively, the cohort literature documents severe impact on independent function: the majority are nonverbal (63%), have global developmental delay (96%), and many have severe-to-profound intellectual disability, implying lifelong dependency for activities of daily living, consistent with other severe DEEs.
DENND5A (DENN Domain-Containing Protein 5A; also historically known as RAB6IP1 — Rab6-interacting protein 1), HGNC:19344, NCBI Gene ID 23258, chromosome 11p15.4. OMIM gene entry *617278; disease entry #617281 (DEE49).
DENND5A contains: - A DENN domain, "an evolutionarily ancient enzymatic module conferring guanine nucleotide exchange factor (GEF) activity to multiple proteins serving as GEFs for Rabs, which are key regulators of membrane trafficking" (PMID:27866705). - RUN1 domain: binds Rab6, which "regulates membrane trafficking and localizes to the trans-Golgi network (TGN)." - RUN2 (C-terminal RUN) domain: interacts with sorting nexin 1. - PLAT domain: site of several disease-associated variants in the expanded cohort (6/30 unique variants). - DENND5A functions as a GEF for Rab39 (Rab39A and/or Rab39B). - The protein contains an autoinhibitory intramolecular interaction between the DENN domain and the RUN1/PLAT domains, producing a "closed" conformation that masks binding sites for apical polarity-complex proteins; an "open" conformation is required for DENND5A to bind MUPP1 (Multi-PDZ Protein 1) and PALS1, core components of the Crumbs apical polarity complex that governs symmetric division of neural progenitor cells (Rodrigues et al. 2024, PMID:39174524). The patient variant p.Arg710His (R710H) destabilizes the closed state and increases MUPP1/PALS1 binding — a gain-of-interaction consequence of a disease variant, distinct from simple loss of GEF activity. - Subcellular localization: DENND5A localizes to the trans-Golgi network/recycling endosome compartment via Rab6, and a distinct pool localizes to γ-tubulin-positive centrosomes in neural progenitor cells, implicated in anchoring astral microtubules to the apical cortex to maintain mitotic spindle parallelism. - DENND5A is "detected predominantly in neuronal tissues with highest levels during development" and is expressed at highest levels in brain, with additional expression in peripheral nervous system and hematopoietic tissue (GeneCards/NCBI).
| Variant (cDNA/protein) | Zygosity | Source | PMID |
|---|---|---|---|
| c.517_518delGA (p.Asp173Profs*8) | Homozygous, family 1 (2 sisters) | Suri et al. 2016 | 27866705 |
| c.2547delG (p.Lys850Serfs*11) | Homozygous, family 2 | Suri et al. 2016 | 27866705 |
| c.1622A>G (p.Asp541Gly, D541G) | Homozygous, 2 unrelated girls | Anazi et al. 2017 | 27431290 |
| c.949+1G>A (splice) | — | ClinVar RCV001808304, "Developmental and epileptic encephalopathy, 49" | — |
| c.2129G>A (p.Arg710His, R710H) | — | Functional/structural characterization; destabilizes autoinhibited "closed" state | Rodrigues et al. 2024 (39174524); ClinVar RCV000623720 |
| 30 unique variants total (25 coding SNVs/indels, 2 CNVs, 3 intronic splice-site variants) across DENN, RUN1, PLAT, RUN2, and linker regions | 14 homozygous / 10 compound heterozygous | Rodrigues et al. 2024 cohort (n=24) | 39174524 |
DENND5A is one of two members of the DENND5 subfamily; its paralog DENND5B causes a distinct (largely non-overlapping) neurodevelopmental disorder via de novo variants, with DENND5B-mutant cells showing defective intracellular vesicle trafficking with impaired lipid uptake/distribution (PMID from PMC10940048/AJHG 2024). Both proteins interact with Rab6, Rab11, and Rab39, and are implicated in synaptic vesicle axonal trafficking and neurotransmitter release.
No environmental factors, lifestyle factors, or infectious agents have been implicated in DEE49 causation or modification in the literature reviewed. This is expected for a fully penetrant autosomal recessive Mendelian disorder.
The pathophysiology of DENND5A-related DEE has been substantially clarified by the 2024 Nature Communications study (Rodrigues et al., PMID:39174524), which used patient-derived iPSCs, CRISPR knockout iPSC lines, a knock-in mouse model, and a zebrafish CRISPR F0 model to define a coherent causal chain from molecular lesion to clinical phenotype.
The original discovery paper proposed a parallel/earlier mechanistic hypothesis centered on Rab-GEF-dependent membrane trafficking of neurotrophin receptors: - DENND5A's RUN1 domain binds Rab6 (trans-Golgi network trafficking regulator); its RUN2 domain binds sorting nexin 1; DENND5A additionally acts as a GEF for Rab39. - "Knockdown of DENND5A leads to striking alterations in neuronal development, and these changes appear to result from upregulation of neurotrophin receptors, leading to enhanced downstream signaling" (PMID:27866705). - In PC12 cells, DENND5A knockdown led to upregulation of TrkA and "significantly enhanced NGF-induced differentiation." In cultured cortical neurons, DENND5A knockdown led to upregulation of TrkB. - Proposed mechanism: loss of DENND5A impairs Rab-dependent lysosomal targeting/degradation of Trk (neurotrophin) receptors, causing their aberrant stabilization at the cell surface; increased Trk levels drive enhanced ERK/Erk activation, altering neurite outgrowth. In neuroblastoma cell contexts, unliganded TrkA overexpression/activation has separately been linked to apoptosis, leading the authors to hypothesize that "upregulation of Trk receptors due to DENND5A deficiency could lead to increased apoptosis in the developing brain" — though the authors explicitly note "the mechanisms whereby loss of DENND5A leads to enhanced amounts of neurotrophin receptor remain unknown."
These two mechanistic threads (apical-polarity/mitotic-spindle-driven premature neurogenesis, and Rab-GEF-dependent neurotrophin receptor trafficking/signaling dysregulation) are not mutually exclusive and both stem from DENND5A's core role as a Rab-GEF/membrane-trafficking regulator; the 2024 paper represents the more mechanistically resolved and cohort-validated model.
Organ level: - Primary organ: Central nervous system (brain), specifically cerebral cortex, ventricular system, corpus callosum, basal ganglia, and (in a subset) posterior fossa/cerebellum. - Secondary involvement: Facial skeleton/soft tissue (coarse facial features are a recognized dysmorphic feature, though not a distinct "organ" pathology per se — likely a downstream/coincidental developmental field effect rather than a primary independent lesion). - Body systems: Nervous system (primary); musculoskeletal system secondarily via hypotonia/spasticity and motor impairment.
Suggested UBERON terms: - UBERON:0000955 — brain - UBERON:0001851 — cortex (cerebral cortex) - UBERON:0002037 — cerebellum - UBERON:0002316 — white matter of corpus callosum / UBERON:0002336 — corpus callosum-adjacent structure - UBERON:0002020 — gray matter - UBERON:0002450 — basal ganglion - UBERON:0035927 — lateral ventricle (ventriculomegaly site)
Tissue and cell level: - Neuroepithelium / apical neural progenitor (radial glia) niche lining the ventricular zone — the primary site of the mitotic spindle-misorientation defect. - Cortical neurons (downstream, prematurely and ectopically generated).
Subcellular level: - Centrosome (γ-tubulin-positive) — DENND5A localization site relevant to spindle orientation. GO Cellular Component: GO:0005813 (centrosome). - Trans-Golgi network — Rab6-dependent trafficking compartment. GO:0005802 (trans-Golgi network). - Recycling endosome — Rab39-related trafficking. GO:0055037 (recycling endosome). - Mitotic spindle — GO:0072686 (mitotic spindle). - Apical plasma membrane / adherens junction — site of Crumbs-complex polarity signaling. GO:0016327 (apicolateral plasma membrane).
Localization: Findings are generally bilateral/diffuse (e.g., bilateral basal ganglia calcifications, generalized microcephaly, bilateral ventriculomegaly) rather than lateralized/asymmetric, consistent with a global developmental defect in neurogenesis rather than a focal lesion.
Onset: Congenital/neonatal-to-early-infantile. The classic severe phenotype has neonatal-onset seizures (per OMIM clinical synopsis); the broader 2024 cohort documents a mean seizure onset of 4.8 months, reflecting a spectrum from neonatal to infantile onset depending on variant severity. The underlying neurodevelopmental insult (impaired progenitor symmetric division) is prenatal, occurring during cortical neurogenesis.
Onset pattern: Insidious-to-acute for seizures (which can present abruptly); the structural brain phenotype (microcephaly, ventriculomegaly, corpus callosum dysgenesis) is congenital and often detectable on prenatal or early postnatal imaging.
Progression: - The structural/developmental brain lesion itself is a fixed, non-degenerative, prenatally-established encephalopathy (progenitor pool is not being progressively lost postnatally by a distinct ongoing pathological process, as far as reported). - The clinical course is one of static-to-progressive global developmental impairment plus refractory, ongoing epilepsy — the DEE label specifically denotes that ongoing epileptic activity itself may contribute to progressive cognitive/developmental decline, a hallmark of the DEE nosological category generally. - Disease duration: chronic, lifelong (no reported spontaneous resolution).
Patterns: - No formal remission-pattern data identified. - No specific "critical period" intervention window has been established in the literature reviewed, although the underlying mechanism (a defect in prenatal apical progenitor symmetric division) implies that the therapeutic window for any mechanism-targeted intervention would need to act prenatally or in early neurogenesis to affect the structural brain phenotype — postnatal interventions would primarily target seizure control and developmental support rather than reversing the structural lesion.
Epidemiology: DEE49 is an ultra-rare disorder. No formal population prevalence or incidence estimate was identified in the literature retrieved (consistent with fewer than ~30 published cases worldwide as of the 2024 cohort study). Given ultra-rarity and recessive inheritance concentrated in consanguineous families (Saudi Arabian, and other reported ancestries in the expanded cohort), it likely falls into an Orphanet prevalence class of "<1/1,000,000" or "unknown/not yet documented" pending a systematic prevalence study.
Inheritance pattern: Autosomal recessive (AR), confirmed by segregation analysis in multiple consanguineous families and by the pattern of homozygous/compound heterozygous genotypes across the full reported cohort (14 homozygous, 10 compound heterozygous of 24 individuals).
Penetrance: Appears to be high/complete for the core homozygous loss-of-function genotype, though phenotypic expressivity is broad (see below) and a subset of biallelic genotypes (particular missense combinations) produce mild-to-absent DEE phenotype, suggesting either incomplete penetrance or (more likely, per the authors) genuinely hypomorphic/less pathogenic alleles rather than true non-penetrance of fully pathogenic alleles.
Expressivity: Markedly variable — ranging from classic severe neonatal-onset DEE49 with microcephaly, refractory seizures, brain calcifications, and coarse facies, to milder presentations with global developmental delay alone, autism spectrum disorder without seizures, or normal neuroimaging, correlating substantially with variant class (truncating vs. missense) and specific residue/domain affected.
Genetic anticipation: Not reported/not applicable (no repeat-expansion mechanism involved).
Germline mosaicism: Not specifically reported in the literature reviewed.
Founder effects: Not formally established, though the concentration of reported cases in consanguineous Middle Eastern (Saudi Arabian) families in the founding reports raises the possibility of population-specific founder or recurrent alleles; this should be confirmed against gnomAD/regional population databases.
Consanguinity: A clearly documented risk factor — both founding families (Suri et al. 2016) and the Anazi et al. 2017 cases arose from consanguineous unions, consistent with autosomal recessive inheritance of a very rare allele.
Carrier frequency: Not established in the literature reviewed; expected to be very low/population-specific given the disorder's rarity.
Population demographics: - Affected populations: Cases have been reported predominantly from consanguineous families, initially Saudi Arabian; the expanded 2024 cohort (22 families) likely includes broader geographic/ethnic representation, though a systematic geographic breakdown was not retrieved in this research pass. - Sex ratio: The 2024 cohort comprised 11 female and 13 male individuals (~1.2:1 male:female) — roughly balanced, consistent with autosomal (non-X-linked) inheritance. - Age distribution: Cohort mean age 9.0 years at time of study (pediatric-to-young-adult range), consistent with a disorder identified and studied primarily in the pediatric population.
Clinical/laboratory tests: No disease-specific biochemical biomarker has been identified; diagnosis relies on genetic testing plus clinical/neuroimaging correlation.
Neuroimaging (a key diagnostic pillar): - Brain MRI: ventriculomegaly, cerebral hypoplasia (reduced brain volume), corpus callosum dysgenesis/agenesis/hypoplasia, and in a subset, Dandy-Walker malformation, posterior fossa cyst, hypoplastic cerebellar vermis, or diffuse hydrocephalus. - Head CT: basal ganglia and periventricular/diencephalic calcifications (as in the original two affected sisters, who had "multiple small foci of calcification in the basal ganglia"). - The authors explicitly recommend: "Individuals with corpus callosum volume changes and/or microcephaly should be screened for DENND5A variants."
Electrophysiology: - EEG: Would be expected to show epileptiform activity consistent with the clinical seizure semiology (focal-to-bilateral tonic-clonic being most common), though specific EEG pattern data (e.g., burst-suppression, hypsarrhythmia) were not detailed in the sources retrieved here and should be confirmed against the primary cohort paper's supplementary phenotype tables.
Genetic testing (the primary diagnostic modality): - Whole-exome sequencing (WES) was the diagnostic method in essentially all reported cases (Suri et al. 2016 used WES in consanguineous families; Anazi et al. 2017 identified their variant via WES of 337 individuals with intellectual disability). - Gene panels: DENND5A is included on Orphanet's "Molecular diagnosis of Epileptic Encephalopathy" gene panel (EPI02v17.1) and commercial early-onset/syndromic epilepsy gene panels (e.g., Genomics England PanelApp "Early onset or syndromic epilepsy" panel and "Hydrocephalus" panel — reflecting the ventriculomegaly/hydrocephalus phenotype overlap). - Chromosomal microarray (CMA): relevant given that 2 of 30 reported variants in the expanded cohort were copy-number variants (deletions/duplications), so CMA/exome CNV calling should be part of a complete diagnostic workup, not single-gene sequencing alone. - Single-gene Sanger confirmation: used in the founding studies to confirm and segregate WES-identified variants within families. - Whole-genome sequencing (WGS) would be expected to have superior sensitivity for detecting intronic splice-site variants (3 of 30 reported variants were intronic).
Screening: No population-based or newborn screening program exists for this ultra-rare recessive disorder. Carrier screening/genetic counseling is relevant primarily in the context of known consanguinity or a family history of an affected individual, given the well-documented consanguinity association.
Differential diagnosis: Other genetic developmental and epileptic encephalopathies presenting with microcephaly, ventriculomegaly, and/or corpus callosum abnormalities (the broader DEE gene panel differential), and other syndromes with coarse facial features and brain calcification (e.g., Aicardi-Goutières syndrome and other interferonopathies presenting with basal ganglia calcification, though these have distinct immunological/inflammatory markers not described for DEE49).
Survival/mortality: No formal survival statistics (5-year/10-year survival, mortality rate) were identified in the literature reviewed; DEE49 is not generally described as directly life-limiting in the sources reviewed, though refractory epilepsy in severe DEEs generally carries elevated mortality risk (e.g., SUDEP risk common to the DEE category broadly) — disease-specific mortality data for DEE49 specifically were not available in this research pass.
Morbidity/function: - Global developmental delay is nearly universal (96% in the 2024 cohort). - 63% of affected individuals are nonverbal. - Intellectual disability severity in a characterized subset: severe (9 cases), profound (3 cases), moderate (2 cases) — indicating substantial lifelong functional impairment for most affected individuals. - No standardized quality-of-life instrument data (EQ-5D, SF-36, PROMIS) were identified for this specific disorder.
Complications: Refractory seizures represent the dominant ongoing complication; hypertonia/spasticity (58%) and hyperreflexia (54%) suggest a significant proportion develop upper motor neuron signs contributing to motor disability.
Prognostic factors: The single strongest documented prognostic factor is variant class — biallelic frameshift/nonsense (complete loss-of-function) genotypes correlate with significantly worse neurological outcome scores than missense genotypes (p=0.0004), making genotype a genuinely predictive prognostic biomarker in this disease, unusual among ultra-rare DEEs for having this level of genotype-phenotype resolution in a cohort of this size.
Recovery potential: No disease-modifying therapy exists; the structural neurodevelopmental lesion (established prenatally via impaired progenitor symmetric division) is not expected to be reversible with current management, which remains supportive/symptomatic (see Treatment section).
No disease-specific, mechanism-targeted therapy currently exists for DEE49. Management is symptomatic/supportive, following general principles for developmental and epileptic encephalopathies:
Pharmacotherapy (symptomatic seizure control):
- Standard anti-seizure medications (ASMs) as used broadly across refractory pediatric DEEs (e.g., valproate, levetiracetam, and other agents used per individual seizure semiology); no DEE49-specific ASM efficacy data (e.g., a published responder series to a particular ASM) were identified in this literature pass.
- NCIT suggestion: NCIT:C15986 (Pharmacotherapy) as the generic treatment_term for ASM use, with individual agents specified via therapeutic_agent (CHEBI) once specific regimens are documented from a primary source.
Dietary/non-pharmacological therapy: - The ketogenic diet is a generally effective option for drug-resistant epilepsy broadly (per general epilepsy literature reviewed: ~16% seizure-free, ~56% with >50% seizure reduction in general drug-resistant cohorts), and would be a reasonable consideration for refractory DEE49 seizures by extrapolation from general DEE/drug-resistant epilepsy management principles — but no DEE49-specific ketogenic diet outcome data were identified in the literature reviewed. - NCIT suggestion: NCIT:C15447 (Dietary Intervention).
Supportive/rehabilitative care: - Physical therapy, occupational therapy, and speech/communication therapy are indicated given the high prevalence of hypotonia/spasticity, motor impairment, and nonverbal status, per general standard-of-care principles for severe DEEs (not DEE49-specific published data). - NCIT suggestions: NCIT:C15302 (Physical Therapy), NCIT:C121351 (Occupational Therapy — per general NCIT catalog), NCIT:C159273 (Speech Therapy).
Genetic counseling: - Recommended for families given the autosomal recessive inheritance pattern and documented consanguinity association, to inform recurrence-risk counseling (25% recurrence risk for future pregnancies of carrier parents) and prenatal/preimplantation testing options once a familial pathogenic variant is identified. - NCIT suggestion: NCIT:C15240 (Genetic Counseling).
Experimental/targeted therapy: None identified in clinical trials (no NCT-registered interventional trial specific to DENND5A/DEE49 was found in this research pass). Given the mechanistic insight that DENND5A loss disrupts a Crumbs-complex/apical-polarity-dependent mitotic spindle orientation mechanism during a narrow prenatal neurogenic window, there is currently no plausible postnatal molecular correction strategy (e.g., no ASO, gene-replacement, or small-molecule approach has been reported), distinguishing this from other monogenic DEEs where postnatal genetic/RNA-based therapies are more mechanistically tractable (since the core lesion is developmental/structural rather than an ongoing biochemical deficiency).
Treatment outcomes / algorithms: No DEE49-specific treatment-response or treatment-algorithm data were identified; management follows general drug-resistant/DEE epilepsy treatment algorithms (sequential ASM trials, consideration of dietary therapy, and supportive multidisciplinary care).
No primary, secondary, or tertiary prevention strategy specific to DEE49 exists beyond standard genetic counseling and reproductive options available for any autosomal recessive Mendelian disorder once a causative variant is identified in a family:
Mouse: Dennd5a orthologue is annotated in Mouse Genome Informatics (MGI:1201681). A knock-in mouse model homozygous for the human-equivalent frameshift variant (c.517_518delGA / p.D173Pfs8) was generated and characterized in the 2024 study: - MRI (7 Tesla): significantly enlarged lateral ventricles (WT 4.8 mm³ vs. KI 6.6 mm³; p=0.034) — ventriculomegaly without overt microcephaly, recapitulating a key human phenotype (dissociation of ventriculomegaly from microcephaly seen in a subset of patients). - Reduced Dennd5a mRNA expression in brain tissue (p=0.046), consistent with nonsense-mediated decay of the frameshift transcript. - Increased seizure susceptibility*: shorter latency to seizure onset upon 4-aminopyridine (potassium channel blocker) challenge (WT latency 23.60 s vs. KI 11.67 s; p=0.007) — a pharmacoconvulsant-provoked seizure-susceptibility phenotype directly modeling the human epilepsy phenotype. - Histology of the adult subventricular zone: significantly increased proportion of NeuN-positive (mature) neurons (WT 39.6% vs. KI 58.8%; p=0.001), directly supporting the "premature neuronal differentiation at the expense of progenitor self-renewal" mechanism inferred from human iPSCs.
Zebrafish: F0 CRISPR knockout larvae (dennd5a orthologue) showed: - Reduced head size - Increased hindbrain ventricle size (p=0.028) — a ventriculomegaly analog - Altered locomotor activity during light/dark cycle assays - Reduced visual and acoustic startle responses - Reduced eye size
This cross-species conservation (mouse ventriculomegaly + seizure susceptibility; zebrafish microcephaly-like/ventricular phenotypes) across two independent vertebrate model systems substantially strengthens causality and supports the fundamental, evolutionarily conserved developmental importance of DENND5A in neurogenesis.
Naturally occurring disease in companion/veterinary species: No naturally occurring DENND5A-associated disease in companion animals or livestock was identified (no OMIA entry found in this search); the described animal models are exclusively laboratory-induced (CRISPR/knock-in), not naturally occurring veterinary disease.
Comparative biology: The core mechanism (Crumbs-complex-dependent apical progenitor symmetric division controlling neurogenesis output) is a deeply conserved developmental biology pathway across vertebrates, explaining why both mouse and zebrafish models recapitulate aspects of the human phenotype despite species differences in brain complexity.
| Model type | System | Genetic modification | Key phenotypes recapitulated | Fidelity/limitations |
|---|---|---|---|---|
| Human iPSC (cellular model) | Patient-derived and CRISPR-KO iPSC-derived neural progenitor cells (neural rosette assay) | DENND5A knockout / patient-derived lines | Mitotic spindle misorientation (57.1°→26.0° mean angle), reduced proliferation, premature β-III-tubulin+ neuronal differentiation | High fidelity for the core cell-autonomous progenitor mechanism; does not model whole-organism seizure phenotype |
| Mouse (in vivo genetic model) | Knock-in mouse, homozygous p.D173Pfs*8 (human-equivalent frameshift) | CRISPR knock-in | Ventriculomegaly (MRI), reduced brain Dennd5a mRNA, increased seizure susceptibility (4-AP challenge), increased mature (NeuN+) neuron proportion in SVZ | Recapitulates ventriculomegaly and seizure susceptibility; did not show overt microcephaly in all mice (partial fidelity to the human microcephaly phenotype — a HUMAN_MODEL_MISMATCH-type caveat) |
| Zebrafish (in vivo genetic model) | F0 CRISPR knockout larvae | CRISPR/Cas9 F0 knockout | Reduced head size, increased hindbrain ventricle size, altered locomotor activity, reduced visual/acoustic startle, reduced eye size | Useful for rapid high-throughput phenotype screening; F0 mosaic knockout (not stable germline line) is a limitation on genotype-phenotype precision |
| Rat pheochromocytoma cell line (PC12) | In vitro neurotrophin-signaling model | DENND5A knockdown (siRNA/shRNA) | Upregulated TrkA, enhanced NGF-induced differentiation | Cancer cell line model of neurotrophin receptor trafficking, not neurogenesis per se; complements but is mechanistically distinct from the 2024 progenitor-division model |
| Primary cultured cortical neurons | In vitro | DENND5A knockdown | Upregulated TrkB | Post-mitotic neuron model; informative for the neurotrophin-signaling arm of the mechanism, not the progenitor-division arm |
Resources: MGI:1201681 (mouse Dennd5a gene page); no dedicated public repository line accession numbers (e.g., IMSR/EMMA/MMRRC ID) were identified in this research pass for the specific knock-in line — this should be confirmed directly from the Nature Communications 2024 paper's Methods/Data Availability section if a specific strain repository accession is needed for curation.
hgnc:19344 (DENND5A)Checked with linkml-reference-validator 0.2.1.
| Outcome | Count |
|---|---|
| References checked | 7 |
| Resolved | 7 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| Quoted claims checked | 1 |
| Quoted claims found in source | 1 |
| Quoted claims not found in source | 0 |
| References weighed for topical relevance | 7 |
| On topic | 7 |
| Off topic | 0 |
All extracted references resolved successfully.